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Here we describe the development of small molecule-based fluorescent sensors for RNA.  The 
sensors described here and the new paradigm they represent are a convergence of chemical and 
biological methods.  The resulting sensor system consists of two components: a rationally 
designed small-molecule fluorescent sensor and a reporter RNA sequence that binds to and 
enhances its fluorescence, isolated with combinatorial biology.  First, we rationally designed and 
synthesized a series of modular fluorescent chemosensors which would be quenched in solution 
and fluorescent only when bound to their target.  These sensors consist of a fluorophore (2',7'-
dichlorofluorescein, DCF) conjugated to a pair of quencher units (aniline derivatives in this case) 
which quench the fluorescence of DCF by the PET (photoinduced electron transfer) mechanism.  
NMR and fluorescent spectroscopic analyses of these DCF derivatives revealed important 
correlations between their conformations, the PET, and fluorescent intensity in addition to 
insight on their solvatochromism and pH dependence.  These studies allowed us to choose a 
candidate sensor for the next step: using combinatorial biology to isolate a reporter sequence.  In 
order to isolate RNA that would enhance the fluorescence of our sensor, RNA that bound to the 
aniline-based quencher was isolated via in vitro selection (a.k.a. SELEX or systematic evolution  
of ligands by exponential enrichment). These RNA sequences (aptamers) were then screened for 
their ability to switch on the fluorescence of the sensor.  One of these aptamers was found to 
enhance the fluorescence intensity of the DCF-aniline conjugate in a concentration-dependent 
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manner, leading to further study of that aptamer with mutation studies and additional in vitro 
selection experiments.  To demonstrate the power and generality of this approach, a parallel in 
vitro selection was performed with aptamers from this selection having similar activities. These 
results show that one can develop fluorescence-inducing reporter RNA and morph it into 
remotely related sequences without prior structural insight into RNA-ligand binding through the 
rational design of fluorescent chemosensors and subsequent isolation of RNA from 
combinatorial libraries.  
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1.0  INTRODUCTION 
Every characteristic of an organism, from the layout of its bodyplan to its susceptibility to 
disease, is controlled by the DNA contained in its cells.  Organized into genes, DNA not only 
carries the blueprint for every protein in the organism, it also carries the instructions for when, 
where and in what quantity these proteins are produced.  It has been long established that genes 
are expressed through the transcription of DNA into RNA, which is then translated into the 
corresponding protein.  Although entire genomes have been sequenced,1-3 the relationship 
between the DNA sequence and phenotype has yet to be fully understood.  Pivotal to this 
understanding is not only determining which gene codes for which protein but how the 
physiological levels of these proteins are controlled by the DNA sequence and gene regulatory 
system. 
To answer these questions, it is necessary to be able to monitor gene expression at the 
DNA, RNA, and protein levels.  Much has been gained in the field of gene regulation through 
the study of proteins.  However, the correlation between the production of an RNA and the 
amount of its corresponding protein is nonlinear in many cases,4,5 leaving a gap in the 
understanding of RNA levels. The recent discovery of RNA interference adds another layer of 
complexity, adding complex regulation at the RNA level.6 Thus, the ability to understand the 
role of the levels, localization and interactions of RNA in living biological systems is essential to 
the study of gene expression.  Central to developing this understanding is the in vivo detection 
and visualization of RNA molecules.  It is then the focus of the research described in this 
document to develop fluorescent sensors capable of detecting RNA. 
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2.0  BACKGROUND 
 
2.1 FLUORESCENT DETECTION AND IMAGING OF RNA 
Due to the relative noninvasivity, high sensitivity and wide array of fluorescence imaging 
techniques, fluorescent bioimaging has become one of the most promising techniques for 
biomolecule visualization and detection.7  The most common tool for fluorescent bioimaging is 
the microscope.  Fluorescence microscopy is dominated by two major classes of instruments: 
conventional optical microscopes and confocal scanning optical microscopes.   
A conventional optical microscope in an epi-fluorescence mode utilizes a filter set to 
limit the light used to illuminate the sample to a chromophore’s excitation wavelength and an 
emission filter to limit the observed light from the sample to the chromophore’s emission 
wavelength.  Central to this filter set, is a dichroic mirror that reflects excitation light to the 
sample and allows the emission light to proceed to the CCD or eyepiece.8  The result is an image 
composed only of light produced by the fluorescence of the sample.  By viewing only the 
fluorescence of specific chromophores, the sensitivity of fluorescence microscopy is two orders 
of magnitude higher than bright-field microscopy.9 Figure 1 shows a typical filter “cube”. 
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Figure 1 Typical filter cube 
Excitatory light from the light source passes through the excitation filter, and is reflected 
by the dichroic mirror to the sample.  The emitted fluorescence from the sample and any 
reflected excitatory light is passed back to the dichroic mirror, where excitatory light is reflected 
back to the light source and emissions are passed through the emission filter to the CCD or 
eyepiece (adapted from 8).  The use of modular filter cubes allows a single instrument to cycle 
through multiple excitation/emission wavelengths quickly, forming super-imposable images for 
multiple wavelength analysis.  To increase sensitivity and allow for convenient documentation, 
the microscope is usually fitted with a CCD detector connected to a PC with image acquisition 
software. 
 Confocal microscopes, confocal laser scanning microscopes in particular, are based on 
optics that allow for scanning of the focal plane, rejecting out of plane, out of focus light.  The 
result is the ability to create optical sections of intact, even living samples.  This ability is 
utilized in the creation of three-dimensional images of thick transparent objects such as whole 
cells or tissues without the need for physical sectioning.10  By illuminating only the focal plane 
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of the sample, the fluorescence emissions or reflections from above and below the focal plane, 
which contribute as out of focus blur to conventional epi-illumination microscopy, are 
eliminated, thereby increasing contrast and sharpness. The use of single point illumination by a 
laser allows for the scanning of a sample, much like a television CRT produces an image by 
scanning across the screen, the laser irradiates one voxtel (3d pixel) of the sample at a time, with 
the image being produced by software that pieces the voxtels into an image.  This contrasts the 
conventional fluorescence microscope where the image is projected onto the CCD image plane 
and the CCD is scanning the already formed image.  Scanning also has the benefit of reducing 
photobleaching of the chromophore. Since only the portion of the sample being scanned is 
illuminated, chromophores out of the voxtel do not get excited, preventing them from becoming 
bleached by extended exposure.  The use of a high-sensitivity PMT instead of a CCD allows the 
confocal microscope to image samples with a lower fluorescent intensity than is possible with 
conventional epi-fluorescent microscopy. 
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 Figure 2 Confocal scanning microscope 
 
Figure 2 shows the confocal principle of epi-fluorescence scanning optical microscopy.  
Monochromatic excitatory light emitted from a laser or other light source is reflected by the 
dichroic mirror, focused through the objective lens onto a diffraction-limited spot in the focal 
plane of the sample.  Fluorescence emissions from the illuminated in-focus voxtel and from the 
out of focus cones above and below it are passed back through the objective lens and through the 
dichroic mirror and emission filter (not shown). Out of focal plane emissions (dotted lines) have 
drastically different image plane foci and are physically blocked from the PMT by the confocal 
aperture resulting in only in-focus rays being detected, and a virtually blur-free image.10 
When more high-throughput fluorescence detection is necessary, fluorescent plate readers 
with the capability of reading up to 1536 well plates offer a commercially available solution.  
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Such plate readers have the benefit of being extremely sensitive: the Victor2 V (Perkin Elmer) 
can detect <2 fmol/well of fluorescein and can be completely automated by integrating robotic 
technology.  
 
2.2 FLUORESCENT IMAGING OF PROTEINS. 
The ability to fluorescently label proteins has revolutionized protein imaging and enhanced our 
understanding of biology.11 Proteins are fluorescently labeled through the production of 
genetically fused chimeras of the target protein with a fluorescent protein such as green 
fluorescent protein (GFP) (Figure 3B) or through covalent derivatization of specific residues 
with commercially available organic dyes. Although GFP approaches can be used to express 
fluorescently labeled chimeric protein in cells and have found many successful applications,12,13 
the bulk of GFP can be detrimental to the structure and function of the target protein.14 Dyes are 
much smaller than fluorescent proteins, but dye-labeled proteins must be introduced into cells by 
microinjection.12  To address both of these problems, Tsien and his colleagues developed the 
FlAsH method,15 which allows proteins containing a tetracysteine motif to be expressed and 
covalently labeled in live cells with a cell permeable fluorogenic reagent. With this method, it is 
possible to rationally design a modular short peptide that can enhance fluorescence when bound 
to a fluorogenic small molecule. 
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2.3 FLUORESCENT IMAGING OF GENE EXPRESSION 
The conjugation of a target protein with a fluorescent or fluorescence-inducing probe is a 
powerful method used to study the biology of proteins (Figure 3B).  Of equal importance is the 
mechanism by which each gene expresses the corresponding protein. Since gene expression is 
controlled by a non-coding regulatory domain that acts independently of the coding region, a 
commonly used technique to monitor gene expression involves replacing the coding region of 
the gene with a reporter gene (e.g. GFP,16 β-galactosidase Figure 3A). A gene encoding a 
fluorescent protein is inserted downstream of the target promoter to study promoter’s activity.  
Expression of the gene results in production of the reporter gene product that then can be 
measured (fluorescent proteins in the case of GFP, or conversion of fluorogenic substrates in the 
case of β-galactosidase assays). 
 
A. Studying promoter activation.
Target
promoter
Fluorescent protein
(reporter gene)
B. Protein labeling
Fluorescent
protein
Target
Protein  
Figure 3 Methods of imaging proteins 
2.4 FLUORESCENT DETECTION OF RNA 
Traditionally, fluorescent detection of non-endogenously fluorescent biomolecules involves the 
introduction of a biomolecule covalently derivatized with a fluorophore, which will then interact 
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with the endogenous species of interest and subsequently be imaged or detected by virtue of the 
fluorescence.17  Various manifestations of this general theme have met with much success in the 
fields of RNA detection and localization. 
2.4.1 Non-Specific RNA Detection 
Non-specific RNA detection involves the detection of RNA regardless of its sequence.  Reverse 
transcription coupled to the polymerase chain reaction (RT-PCR) is one such strategy.  In this 
biochemical technique, RNA is isolated from cells or produced via in vitro transcription 
reactions.  First strand synthesis of complementary DNA (cDNA) is produced via the reverse 
transcriptase enzyme.  This single-stranded DNA (ssDNA) is then amplified via polymerase 
chain reaction (PCR) and separated by length using gel electrophoresis.  If quantitative 
information is desired, commercial instruments for real-time quantitative RT-PCR measurements 
are available.  One such system, the ABI Prism 7700 sequence detector (TaqMan; Perkin Elmer/ 
Applied Biosystems), allows for real-time fluorescence spectra to be measured in a 96 well plate 
format for high-throughput analysis. Although the reverse transcription step is the same, real-
time PCR differs from standard PCR in that a non-extendible fluorogenic probe is used to 
continuously monitor PCR product during the reaction.  This probe consists of a fluorophore and 
a quencher covalently attached to the 5’ and 3’ ends, respectively, of an oligonucleotide 
sequence complementary to a portion of the ssDNA to be extended.  A common 
fluorophore/quencher pair is 6-carboxyfluorescein (FAM) and 6-carboxytetrametnylrhodamine 
(TAMRA).  When the probe is intact, the FAM fluorescence is quenched by the proximal 
TAMRA.  During the extension phase of PCR, the 5’ nuclease activity of Taq polymerase 
hydrolyses the probe.  The subsequent increase in FAM emission is correlated to the initial 
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amount of template. Using this emission data, the system’s software constructs amplification 
plots from which starting copy numbers can be determined.18 
The most significant limitations of RT-PCR analysis are the lack of information 
regarding mRNA localization and the difficulty of quantitative extraction of mRNA from intact 
tissues.19  RNA isolation involving the digestion of tissue slices with proteinase K and 
subsequent isolation of RNA with chloroform extraction19 does not allow for anything more than 
tissue-specific information regarding mRNA localization.  The isolation of RNA using such 
methods consistently results in contamination from genomic DNA (gDNA).20  The purity of an 
RNA template is crucial to quantification of initial RNA since this gDNA is often amplifiable 
despite careful primer design.  Pretreatment of the RNA with DNase is of limited utility as 
DNase has been shown to degrade RNA resulting in the reduction or even loss of low-copy RNA 
transcripts from small tissue samples.20 
With the commercial availability of fluorescently-labeled nucleotides (NTPs) and 
deoxynucleotides (dNTPs) such as fluorescein-12-uridine-5’-triphosphate (FITC-UTP) (see 
Figure 4) the synthesis of fluorescently-labeled DNA and RNA has become common. 
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Figure 4 Fluorescein-12-uridine-5’-triphosphate (FITC-UTP) 
 10 
These labeled NTP’s and dNTP’s are incorporated directly into DNA or RNA during standard 
chemical synthesis or can be enzymatically incorporated into RNA and DNA by their respective 
polymerases.21  One such application of fluorescently-labeled nucleotides is the labeling of 
nascent RNA transcripts in living cells.  After the microinjection of FITC-UTP into the 
cytoplasm and subsequent extraction of unincorporated label, the cells are visualized for RNA 
incorporation by confocal fluorescence microscopy.22  This technique was used to detect and 
localize nascent RNA to PML (promyelocytic leukemia) gene product and coiled bodies in the 
nucleus. Labeling RNA in vivo through incorporation of fluorescent nucleotides is relatively 
simple to perform and has the advantage that areas inaccessible to antibodies can be imaged, but 
no sequence specificity is afforded due to the universality of the labeled NTPs. 
2.4.2 Sequence-Specific RNA Detection and Imaging 
When the detection of specific RNA sequences is necessary, techniques involving fluorescent 
oligonucleotide probes are employed.  Fluorescent oligonucleotide probes are short (15-50 bases) 
stretches of ssDNA or RNA with sequences complementary to the target RNA and containing 
one or more fluorescent labels.  These antisense probes provide sequence specific detection 
through Watson-Crick base pairing with the RNA of interest. The probes can be chemically 
synthesized using commercially available DNA synthesizers or through enzymatic means by 
incorporation of labeled bases into PCR or in vitro transcription reactions.  In addition, many 
commercial and private oligonucleotide synthesis facilities offer the synthesis of fluorescently-
labeled probes with a wide range of excitation and emission wavelengths. 
One of the earliest and probably the most popular method of sequence-specific RNA 
detection is the Northern blot.  In a Northern blot, cells are lysed and the isolated  RNAs are size-
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fractionated on a gel and transferred to a nitrocellulose or nylon membrane by capillary or 
electrophoretic transfer.  The nucleic acid is immobilized onto the membrane by UV cross-
linking, by baking at 80°C, or by alkaline transfer.  The membrane is then washed and 
hybridized with a biotin- or fluorescein-labeled probe.  After hybridization, the unbound probe is 
removed with multiple post-hybridization washes.  The membrane is then incubated with a 
protein block to reduce non-specific interactions, and the bound probe is detected by incubating 
the membrane with a series of antibodies against the probe label (biotin or fluorescein).23  
Although it allows for the sequence specific detection of target RNA, performing a northern blot 
analysis is time consuming, and like RT-PCR analysis, it supplies no information about location, 
origin or dynamics of RNA. 
 
B: Molecular Beacons
Target RNA
A: Fluorescent
Oligonucleotide Probes
(FISH, FIVH)
Target RNA
 
Figure 5 Methods of RNA imaging: FISH, FIVH and Molecular Beacons 
 
For more cellularly relevant information, it is important to be able to image RNA in intact 
cells.  Building on the use of antisense fluorescent probes, fluorescence in situ hybridization 
(FISH, Figure 5A) is conceptually similar to a northern blot except that the RNA is hybridized in 
intact cells instead of being isolated and electrophoretically separated.24  Applicable to the 
detection of both DNA and RNA, FISH is probably the most popular method of RNA imaging 
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with applications ranging from localization of a specific RNA sequence within a particular cell 
organelle to monitoring the gene expression of an intact organism.  In a typical FISH experiment, 
the cells to be viewed are first fixed and pre-treated with proteases or detergents to allow the 
non-cell permeable probes entry into the cell.  Hybridization of the probe occurs easily through 
the permeabilized membranes of the fixed (killed) cells and the cells are stringently washed to 
remove unbound probe before visualization.24  The sequence(s) of interest are then visualized 
with fluorescence microscopy by virtue of the fluorescent hybridized probe. 
When using FISH to detect RNA, RNA probes synthesized from cDNAs of the RNA of 
interest are generally used due to the more stable nature of RNA-RNA hybrids compared with 
DNA-RNA hybrids.24  Through the use of transcription vectors, large amounts of sense (negative 
control) and anti-sense (specific) RNA probes can be produced.  It has also been shown that non-
specific probe binding can be reduced by a post-hybridization RNase treatment and the fragment 
length can be controlled by alkaline hydrolysis treatment during the production of the probes.24 
One of the greatest benefits of using fluorochromized probes in conjunction with 
fluorescence microscopy is the ability to study gene expression using combinations of spectrally 
distinct chromophores to visualize several RNA sequences in a single tissue or cell section.  
Dirks and Raap demonstrated this ability when they detected histone H3 mRNA simultaneously 
with, respectively, human cytomegalovirus immediate early (HCMV-IE) and luciferase mRNA 
in two different cell lines.25  The use of tetramethylrhodamine-4-dUTP and digoxigenin-12-
dUTP, the latter coupled to a series of fluorescein-labeled antibodies, facilitated visualization 
with a dual-pass filter.   
Due to the harsh fixation and cell pretreatment procedures employed in FISH 
experiments, the deterioration of cell morphology and the disturbance of RNA localization 
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becomes likely.20  Information about the dynamic behavior of RNA (namely synthesis, transport 
and processing) is gained more appropriately through the study of living cells in real-time 
fluorescent microscopy.  It is for this reason that the field of fluorescence in vivo hybridization 
(FIVH) has grown in popularity. 
Although the basic concepts of FIVH and FISH are the same (visualization of hybridized 
probes in intact cells) performing the hybridization in living cells poses some significant 
challenges.  The most significant and first to be encountered is the efficient introduction of 
fluorescently-labeled probes into living cells without irreversibly altering their morphology and 
viability.  The main obstacle is the cell membrane, and for nuclear RNA detection, the nuclear 
membrane.26  Many techniques have been devised to pass the membranes.  One of the least 
obtrusive makes use of pinocytosis, a naturally occurring uptake mechanism of cells.27  Through 
pinocytosis, small amounts of probe can be taken up by a cell in pinocytotic vesicles and 
released into the cytoplasm after a hypertonic treatment of the cells. The major drawbacks of this 
approach are the large amounts of probes needed and the cell damage incurred by the hypertonic 
treatment that is needed to disrupt the pinocytotic vesicles before they fuse with lysosomes in the 
cytoplasm. 
Although less effective, the mechanical methods of scrape and scratch loading have also 
been used to introduce exogenous molecules.  Scrape loading, used with adherent cells, involves 
scraping the cells from their substratum into medium containing the probe to be introduced.26  
Scratch loading, a related technique utilizes mild injury through scratching of the cells with a 
sharp instrument while in probe containing medium.  Upon recovery, the probe can be visualized 
in the effected cells.7  More effective than scratch and scrape loading is the technique of bead 
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loading, where the probe solution, mixed with 75-150 µm glass beads is gently agitated with the 
cell culture, causing small legions in the membrane where the probes can enter.26 
Due to its direct and quantitative nature, microinjection via micropipettes is a powerful 
technique for probe introduction.28  After being delivered into the cytoplasm, small sized probes 
have been shown to freely diffuse into the nucleus within seconds.  For larger probes, 
microinjection directly into the nucleus is possible.26  Despite the popularity of this technique, it 
requires that each cell to be studied be individually injected, a technique that needs specialized 
equipment and is not trivial to master. 
After the introduction of the probe, a problem plaguing FISH and FIVH is the removal of 
unbound probe.  Since there is no means to distinguish bound from unbound probe, failure to 
completely remove unbound probe results in increased background fluorescence.  Unlike FISH 
where stringent chemical washes are used, in FIVH techniques, cell viability is important, so 
high background due to unbound probe is a problem.  For this reason, techniques developed to 
distinguish the hybridized signal from the omnipresent cell autofluorescence and unbound probe.  
The ideal probe for live cell studies is one that is non-fluorescent when introduced into a cell and 
fluoresces only upon hybridization with its target.  Molecular beacons,29 originally designed for 
real time PCR, are one approach to solving this problem (Figure 5B).  They consist of a single 
stranded nucleic acid with a fluorescent chromophore at one end and a quencher at the other (see 
Figure 5C,D).  The molecule forms a stem-loop structure with a 15-20 base loop sequence, 
complementary to the target nucleic acid, flanked by two sequences complementary to each other 
which anneal, forming the “stem”.  When in closed conformation, the proximity of the 
chromophore and quencher dictate that the molecule is quenched, during hybridization to the 
target sequence, the molecular beacon opens separating the quencher and chromophore, restoring 
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fluorescence.  Although effective in concept and homogeneous solution, Dirks et al26 has 
observed that when injected into the cytoplasm, molecular beacons open up immediately upon 
entering the nucleus.  The authors speculate that the beacons’ transient association with nuclear 
proteins is the cause for this instantaneous opening, but this relationship has yet to be proven.  
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Figure 6 Methods of RNA imaging: FRET and RNA-GFP conjugates 
 
An alternative approach is fluorescence resonance energy transfer (FRET, Figure 6A).  
With careful probe design, two probes labeled with donor and acceptor fluorophores, 
respectively, are hybridized to adjacent sequences on the target molecule. When the fluorophores 
are within 10 nm, the emission from the donor fluorophore will excite the acceptor, yielding a 
shift in fluorescent emission from the donor to the acceptor.  The fluorophores must be chosen 
carefully, however because in order for FRET to occur, the emission spectrum of the donor 
chromophore needs to overlap with the excitation spectrum of the acceptor chromophore.26  The 
FRET approach was used by Tsuji et al30 for the detection of c-fos mRNA in the cytoplasm of 
transfected Cos7 cells.  FRET has also been used to monitor nascent transcripts in the real-time 
monitoring of in vitro transcription by Tsuji’s group.31 
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One method used to study RNA localization involves the introduction of fluorescently-
labeled versions of target RNA into living cells monitoring their spatial and temporal distribution 
by live cell fluorescence microscopy.  This RNA is typically labeled by the incorporation of 
fluorescent nucleotides during in vitro synthesis from full-length cDNA or by 3’ end chemical 
labeling.  In one of the earliest applications of this approach, Wang et al.32 demonstrated that 
microinjected β-globin pre-mRNA localizes in speckle domains which are enriched for 
spliceosome components.  From these early observations, they concluded that the intracellular 
movement of pre-mRNA to spliceosome regions is not necessarily coupled with transcription.  
With the microinjection of signal recognition particle (SRP) RNA, Thoru Pederson’s group was 
able to track the movement of the SRP RNA in real time.33  Within 5 minutes of nuclear 
microinjection, the SRP RNA was observed to localize in the nucleoli followed by a progressive 
decline in nucleolar fluorescence and an increase in signal at various cytoplasmic foci.  With 
injection into the cytoplasm however, the RNA neither entered the nucleus nor concentrated in 
any specific locations in the cytoplasm.  These data suggest that the SRP RNA was somehow 
processed in the nucleoli or assembled into a ribonucleoprotein particle for export into the 
cytoplasm.  Microinjecting labeled RNA into living cells yields much information about 
localization and dynamic behavior, but it should be noted that due to the higher concentration of 
labeled RNA than would be present for the corresponding endogenous RNA, the existing cellular 
transport and processing routes may become saturated forcing the exogenous RNA molecules to 
follow different routes with different kinetics.26 
An approach pioneered by the Singer group dispenses with organic chromophores 
altogether. Singer’s system uses GFP fused to RNA binding protein MS2 to detect specific RNA 
in living cells (Figure 6B).34-36   Used primarily to track RNA localization, the reporter sequence 
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that contains repeated MS2 protein binding motifs is inserted between the gene of interest and 
the RNA localization signal.34  Although this technique has been used to study RNA 
localization,34,37-39 RNA dynamics,35,40,41 and transcriptional profiling,36,42 it has several 
disadvantages.  Most significantly, it has a low signal to noise ratio caused by presence of 
overexpressed, fluorescent MS2-GFP protein (the binding of RNA to the protein merely 
localizes the protein on the RNA, it does not elicit any change in the fluorescence).  To combat 
the low signal to noise ratio, the authors employ a series of multiple repeats of the MS2 binding 
sequence, resulting in 24 to 96 individual MS2-GFP proteins bound to a single RNA,35 likely 
causing the RNA to behave differently inside the cell.  Lastly, in addition to the gene of interest, 
the expression of the MS2-GFP conjugate must be tightly regulated using a constitutive 
expression system, further complicating live cell experiments.43 
2.5 PET-BASED SENSORS 
Since our approach relied on the implementation of small molecule fluorescent sensors, and such 
molecules have seen limited application in the imaging of biomacromolecules, we turned to the 
widely successful field of fluorescent metal ion probes for inspiration.44-51  An ideal probe for 
metal ions (or RNA) is non-fluorescent when free in solution and fluorescent only when bound 
to a specific target molecule.  Such an off-on fluorescent sensor can rationally designed by 
implementing by the photoinduced electron transfer (PET) mechanism to modulate the 
fluorescence (Figure 7).52  Fluorescence occurs when a fluorophore is excited with the 
appropriate wavelength of light, and an electron from the HOMO is promoted to the LUMO. The 
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decay of this electron back to the HOMO is accompanied by the release of energy in the form of 
a photon of light (Figure 7A). 
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Figure 7 Fluorescence quenching as described using frontier molecular orbitals 
 
When a quencher is present near a fluorophore and its HOMO energy level is between 
the HOMO and LUMO energy levels of the fluorophore (Figure 7B), PET occurs from the 
quencher to the excited fluorophore, forcing the excited electron to decay by non-radiative 
means, resulting in reduced fluorescence.  The fluorescent intensity of such a sensor is correlated 
to the HOMO energy level of the quencher(s) as shown in the Rehm-Weller equation (Eq 1; Eox 
= oxidation potential of a quencher, Ered = reduction potential of a fluorophore, ∆E00 = the singlet 
excited energy, wp = the work term for the charge separation state).53  
 
∆GPET = Eox – Ered –∆E00 - wp (Eq 1) 
 
 As this equation indicates, increasing the HOMO level of the quencher (Eox) 
thermodynamically and kinetically favors PET, thus reducing fluorescence signal.  The binding 
of an analyte such as a metal ion can deactivate the quencher by lowering the HOMO level of the 
 19 
quencher and restoring fluorescence (Figure 7C).  This correlation between the HOMO-LUMO 
gap and fluorescent intensity is well established.54 
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Figure 8 Intracellular calcium and zinc sensors 
 
The modularity of PET-based ion sensors can be illustrated by comparing the Ca2+ and 
Zn2+ sensors shown in Figure 8.  Although attached to different chromophores, the 
tetracarboxylate ligand binding groups are conserved between the Ca2+ sensors FURA-255 and 
calcium green-156 and have relatively similar Kd values of 24 nM and 190 nM, respectively.  The 
intracellular Zn2+ sensors ZnAF-2F57 and Zinpyr-4,58 with Kd values of 5.5 nM and 0.65 nM, 
respectively, contain the same fluorescein scaffold and zinc chealator dipicolylamine acting as 
the ligand-binding switch, but differ in their point of attachment.  For ZnAF-2F, with its 
quencher moiety on the benzoic acid, the enhancement of fluorescence was shown to be 60 fold 
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upon the addition of Zn2+ 57 whereas Zinpyr-4, with its quencher moieties on the xanthene ring, 
exhibited 5.7 fold enhancement.58  The quenched quantum yield of the ZnAF-2F is only 0.006, 
but upon enhancement, becomes 0.24.57  Zinpyr-4, with a higher background (quenched) 
quantum yield of 0.06, is enhanced to 0.34.59  From these data, and that of the previous Zn2+ 
sensor Zinpyr1,59 it becomes apparent that although substitution on the benzoic acid of 
fluorescein results in more efficient quenching and the enhanced fluorescence is not as intense, 
resulting in sensors capable of a lower background fluorescence.  When quenching from the 
xanthene (as in Zinpyr-1), although the quenching of fluorescence may not be as efficient, the 
enhancement is more significant, with an enhanced quantum yield of 0.92 as compared to 0.95 of 
fluorescein (as a reference standard, in 0.1N NaOH59), indicating that the effect of the quencher 
is almost entirely deactivated through the binding of the ligand. 
In principle, the deactivation of the quencher can also be accomplished by increasing the 
quencher-fluorophore distance, reducing PET efficiency (Figure 8C).  The dependence of 
quenching efficiency on distance is known to be proportional to e-βd, where d = the distance 
between the HOMO electrons of the quencher and the fluorophore.  In other words, PET 
efficiency decreases as the quencher-fluorophore distance increases, allowing efficient radiative 
decay (i.e., stronger fluorescence) to occur from the LUMO to the HOMO of the fluorophore 
when the quencher is sufficiently distant.  The use of this conformational switch is rare in sensor 
development, limited to only one example.60,61 
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Figure 9 Unquenching of PET-dependent  fluorescence 
 
To summarize PET-dependent fluorescence, (Figure 9) for a PET sensor to be switched 
on, an analyte must lower the HOMO energy level of the quencher and/or increase the distance 
between the quencher and the fluorophore. 
2.6 IN VITRO SELECTION 
In vitro selection (AKA SELEX) is a combinatorial biology technique used to isolate RNAs with 
a rare activity (such as binding a small molecule) from a population of random sequences.62-64 
Briefly, in this technique (Figure 10), a chemically synthesized random library of 1013-1015 DNA 
molecules is transcribed into RNA and incubated with an affinity column containing the desired 
ligand in binding buffer containing a high Mg2+ concentration (Mg2+ has been shown to be a 
necessary cofactor for RNA binding62).  After several washings to remove unbound species, the 
bound RNA is eluted, reverse transcribed into cDNA and amplified by PCR (usually as one step 
RT-PCR).  This PCR library becomes the template for the RNA of the next round of selection.  
The fraction retained by the column increases with each subsequent round until the population is 
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dominated by binding sequences (aptamers).  Three to 15 rounds of selection is typically 
sufficient to “purify” away the non-binding RNA aptamers.65  After the aptamers are sequenced, 
more detailed activity studies are conducted, such as determination of KD or fluorescence 
enhancement (Figure 10). 
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Figure 10 Systematic Evolution of Ligands by EXponential enrichment (SELEX) 
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Figure 11 Screening of aptamers for fluorescence restoration ability 
 
 
 24 
3.0  RESULTS AND DISCUSSION 
3.1 GENERAL APPROACH FOR RNA CHEMOSENSORS 
With the limitations of existing methods of RNA detection in mind, we set out to develop 
a new method of in vivo RNA detection based on the visualization of nascent RNA transcripts 
via membrane permeable sensor molecules whose fluorescence was controlled by specific RNA 
interaction.  Since no generally applicable approach existed for the rational design of small 
molecule fluorescent sensors to detect RNA, we had the added challenge of devising the 
approach as well as developing the sensor system. To accomplish this, we needed two things. 
First, a cell-permeable fluorescent sensor was needed possessing both an affinity for RNA and 
some type of spectral change upon association with specific RNA sequences.  Such a spectral 
change could be a significant increase in fluorescent intensity, a visible change in emission 
wavelength, or both. Second, we needed to identify a specific RNA sequence that would bind 
tightly to this molecule and elicit such a spectral change.  The resulting system would consist of 
an expressible RNA reporter sequence that would function as a reporter gene, binding to the 
sensor forming a fluorescent complex detectible via fluorescence microscopy or high-throughput 
plate reader. 
With this system, the sensor molecule would be fluorescent only when bound to the 
target RNA. Such a sensor is depicted in Figure 12. On the left, a conventional FISH or FIVH 
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experiment is shown where the excess fluorescent unhybridized probe is present in the cell 
leading to increased background signal.  On the right, detection via RNA-specific sensor 
molecules is shown: the reporter (sensor-binding) sequence is appended to the target RNA, 
forming a fluorescent complex with the sensor while the unbound sensor molecule remains non-
fluorescent in the cell. The implementation of this type of sensor system will result in low 
background due to unbound probe in addition to the generality of a reporter sequence able to be 
applied to virtually any gene of interest. 
 
Detection via
RNA-specific Sensor Molecules
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Figure 12 RNA-specific sensor  molecules 
3.2 NEOMYCIN DERIVITIZATION 
To initiate our project into the development of fluorescent RNA sensors, we thought it 
apt to start by designing a modular sensor consisting of a known small molecule RNA ligand 
conjugated to a fluorophore.  We surmised that such a molecule would be able to detect the 
small-molecule binding RNA by virtue of the attached fluorophore’s fluorescence (or 
perturbation there of). 
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Due to its well studied interaction with the Rev-response element of HIV-1 virus66-72, the 
aminoglycoside antibiotic neomycin B was chosen to serve as the RNA ligand.  Neomycin has 
been shown to bind tightly to this RNA with an affinity of 82 nM70 and also to affect the 
fluorescence of covalently attached fluorophores.73  We then chose to conjugate neomycin to the 
fluorophore fluorescein through a scheme (see Scheme 1) developed to form neomycin-acridine 
conjugates.73  
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Scheme 1 Neomycin-fluorescein conjugate synthesis 
 
Synthesis of Boc protected compound 1 and TIBS substituted compound 2 were achieved 
in 53% and 65% yields, respectively.  Unfortunately, due to the complicated nature of the 
resulting NMR spectra and unreliable instrumentation used for fast atom bombardment mass 
spectrometry (FAB-MS) analysis, we were unable to fully characterize these neomycin 
derivatives, although the mass of 2 was verified by electrospray MS.  The product from the 
subsequent conjugation with aminofluorescein was unable to be purified, although it was visible 
on TLC.  This neomycin-based approach was abandoned due to slow progress caused by the 
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extreme length of the TIBS substitution reaction, the difficulty of structure verification and the 
difficulties encountered in the purification of the final product. 
3.3 MODULAR SENSORS 
3.3.1 Rational Design of Modular PET Sensors 
In light of these difficulties, we decided to simplify the RNA ligand portion of the sensor and 
revise our approach.  Instead of designing a known RNA-ligand interaction into the sensor, we 
would concentrate on designing fluorescence switching into the sensor and leave the RNA-ligand 
interaction to combinatorial biology.  Through the implementation of a synthetic scheme 
amenable to creating a diverse library of sensors, we would be able to increase the possibility of 
finding a RNA-sensor interaction appropriate for use in living cells. 
 Using successful PET sensors such as those described above as a guide, we set out to 
rationally design a modular PET sensor to detect RNA. For the fluorophore portion of the sensor, 
we chose 2’,7’-dichlorofluorescein (DCF). Known for their high quantum yields, fluorescein 
derivatives are commonly used in fluorescently-labeled nucleotide analogs as well as calcium 
green and the Zn2+ sensors described above, many of which are membrane permeable.  A widely 
used fluorophore in bioimaging, DCF, was chosen because its fluorescence is pH-insensitive 
under physiological conditions unlike fluorescein (the pKa of the hydroxy group of DCF and 
fluorescein are 5.274 and 6.5,75 respectively), DCF is brightly fluorescent (Φ = 0.85), and the 
chloride groups block two of the possible four nucleophilic centers, enabling us to use DCF as a 
nucleophile without regioselectivity issues.  Dichlorofluorescein’s high quantum yield is 
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important to maximize the signal-to-noise ratio inside cells. Chromophores based on the 
fluorescein scaffold with excitation and emission wavelengths around 490 and 525 nm, 
respectively, facilitate use in confocal microscopes and plate readers since no quartz optics are 
needed (as with UV excitable chromophores).  Their absorption at 490 nm allows them to be 
excited with the 488 nm line of the argon-ion laser utilized in most confocal laser scanning 
microscopes and also the standard filter sets of fluorescent plate readers and conventional epi-
fluorescence microscopes.   
 The choice of a fluorescence switch was not as straightforward. In order to maximize 
sensitivity, it is important that the difference in fluorescence from bound to unbound sensor be as 
large as possible.  The challenge was then to find a quencher moiety that would efficiently 
transfer electrons to the xanthene core of DCF yet be able to have that electron transfer 
reversibly interrupted by RNA binding.  We chose aniline derivatives for this purpose due to 
their low pKa values and high HOMO energy levels and diverse selection of commercially 
available analogs. Nitrogen containing groups have been incorporated into many sensors to 
control fluorescence via PET.55,57,59  They are also vital to many RNA ligands such as the 
aminoglycoside antibiotics that owe their potency to tight complexes with RNA. This affinity is 
not reserved for naturally occurring RNA sequences, however.  In vitro selected RNA for 
tobramycin has been found with a Kd of 6 nM.76 
Based on these criteria we designed model compound 4 and sensor candidate 5 (scheme 
2).  We hypothesized that the lone pairs on the aniline nitrogens would effectively quench the 
fluorescence, yet still permit the molecule to be unquenched if the lone pairs were to become 
complexed with RNA.  To verify that the aniline nitrogens were responsible for PET quenching, 
we designed analog 6. Since the quenching ability is proportional to the electron density (the 
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higher the electron density the greater the quenching ability and lower the fluorescence), we 
mused that by tuning the electron density of the aniline ring, we could control the fluorescence of 
the resulting sensor.  To test this, we designed analog 7 with chloride as an electron withdrawing 
group and analogs 8 and 9 with a methoxy group to increase electron density. 
3.3.2 Synthesis of DCF Derivatives 
Model compound 4 and its related DCF derivatives (Scheme 2) were prepared by means 
of Mannich reactions between DCF and the corresponding commercially available secondary 
amine according to the procedure of Burdette et al.59  Silica gel chromatography and 
recrystallization afforded products 4, 5, 6 and 9 (DCF-2MPP) in yields of 85%, 73%, 77% and 
39%, respectively.  The synthesis of derivative 7 was unsuccessful due to the decomposition of 
the product before it could be isolated.  Compound 8 was formed as an insoluble polymer and 
also was not isolated. Dr. Shahi in the Koide group prepared compound 10 to function as a 
control containing only one MPP quencher unit as described in Org. Lett. 2004, 6, 1947–1949. in 
detail.77 
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Scheme 2 Derivitization of DCF 
3.3.3 Analysis of Candidate Sensors 
3.3.3.1 Absorbance and Fluorescence Emission 
We then gathered absorbance and fluorescence data on compounds 4, 5, 6, DCF-2MPP 
and 10 in a pH 7 phosphate buffer (Table 1 and Figure 13). As expected, the model compound 4 
displayed a low quantum yield (Φ) of 0.052, compared to its parent fluorophore DCF (Φ of 
0.85), revealing that compound 4 or its related compounds would exhibit a large increase in 
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fluorescence if the PET can be suppressed. The significant role that the aniline nitrogens played 
in the PET quenching was revealed with the lack of aniline nitrogen atoms in compound 6 
causing a high Φ of 0.710. This is consistent with the electrons of the aniline system being 
coupled to the relaxation of the excited chromophore. Although we were unable to synthesize the 
electron deficient 7, we were still able to correlate the electron density of the quencher to its 
ability to quench the fluorescence.  We hypothesized that based on the Rehm-Weller equation 
(Eq 1), the electron donating nature of the methoxy group of para-methoxyaniline derivative 
DCF-2MPP would cause it to be less fluorescent than aniline derivative 4.  This hypothesis was 
confirmed when we found the quantum yield of DCF-2MPP to be 0.025, significantly lower than 
that of compound 4.  Further support correlating the HOMO energy level to the fluorescence was 
found in compound 5.  The electron withdrawing nature of the pyridine ring of 5 compared to the 
phenyl ring of 4 gives the quenchers of 5 a lower HOMO level, rendering their quenching less 
favorable. This is evidenced in the higher quantum yield of compound 5 compared to that of 
compound 4 (Φ = 0.102 and 0.052, respectively).  To illustrate the effect of the number of 
quencher units on the fluorescent intensity, we tested the mono-substituted analog of DCF-
2MPP, finding the quantum yield of 10 to be 0.176, suggesting that the quenching of the di-
substituted compounds is cooperative rather than additive.  This cooperative quenching concept 
is currently being explored by others in the lab. 
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 Table 1 Spectroscopic data in a pH 7 phosphate buffer. 
Compound 
λab-max 
(nm) 
λem-max 
(nm) Φ 
4 507 524 0.052 
5 508 522 0.102 
6 504 522 0.710 
DCF-2MPP 508 528 0.025 
10 512 533 0.176 
DCF 502 522 0.850 
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Figure 13 Relative intensities of DCF derivatives 
3.3.3.2 Solvatochromism in UV Absorbance 
While working up the first two compounds we synthesized (phenyl compound 4 and 
pyridinyl compound 5), color shifts were observed when transferring the compound from one 
solvent to another. Although not essential to the overall goal of designing RNA sensors, this 
solvatochromism intrigued us and we decided to spend a brief period exploring it.  The 
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solvatochromic properties of compounds 4 and 5 were investigated by acquiring absorbance and 
fluorescence emission spectra in 0.1N NaOH, MeOH, pH 7.4 phosphate buffer, MeCN, CH2Cl2, 
and CHCl3.  Figures 14 and 15 show the absorbance spectra of compounds 4 and 5, respectively.  
In both spectra, two distinct groups of λmax values emerge: NaOH, pH 7.5 buffer, and MeOH, 
clustered around 510 nm and DMSO, CHCl3, MeCN and CH2Cl2, grouped around 535 nm.  With 
the exception of DMSO, changes in absorbance intensity accompany the shifts, with CHCl3, 
MeCN and CH2Cl2 having nearly an order of magnitude less absorbance than NaOH, pH 7.5 
buffer, MeOH and DMSO.   Although the reason for these shifts has not been ascertained, we 
hypothesize that it is due to a conformational change caused by solvent, by which the molecule 
assumes a different conformation in polar and non-polar solvents. Attempts to lend support to 
this hypothesis by means of NMR were unsuccessful, with compounds 4 and 5 lacking sufficient 
solubility to obtain useful spectra in solvents other than DMSO-d6. 
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Figure 14 Absorbance spectrum of compound 4 
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Figure 15 Absorbance spectrum of compound 5 
3.3.3.3 Solvatochromism in Fluorescence Emission 
Further evidence of solvatochromism can be found in the fluorescence emission spectra.  
Fluorescence samples were prepared as stated above for the absorbance experiment with the 
exceptions of CHCl3 and CH2Cl2, which were omitted due to poor absorbance of compounds 4 
and 5 and insolubility at higher concentrations.  Figures 16 and 17 compare emission spectra for 
0.1N NaOH, MeOH, pH 7.4 phosphate buffer and DMSO.  The emission spectra show similar 
solvent-dependent effects; with DMSO and MeCN being red-shifted in relation to NaOH, pH 7.5 
buffer, and MeOH.  The fluorescent intensities of NaOH, pH 7.5 buffer, and MeOH are inversely 
related to their respective absorbances.  In Figure 19, the intensity of compound 5 in pH 7.4 
phosphate buffer is approximately 3.5 times that of 0.1 N NaOH, suggesting a pH dependence. 
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Figure 16 Emission spectra of compound 4 in various solvents 
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Figure 17 Emission spectra of compound 5 in various solvents 
3.3.3.4 PH dependence of Fluorescence Emission 
To further explore this pH dependence, we took a series of spectra in phosphate buffer 
solutions of varying pH from 2.5 to 12.5 (Figures 16-19).  While compounds 4 and 5 are 
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quenched equally at basic pH (Figure 18), the intensity of compound 5 increases sharply below 
pH 4.5 by 8-fold, while compound 4 increases a modest 2-3 fold.  Due to the fact that both 
aniline and pyridinyl nitrogens can have pKa values in this range, it is not obvious which 
nitrogen becomes protonated first.  We had hoped to use these data to distinguish between the 
two, but due to the lack of a definite inflection point this was not possible.  The wavelength of 
the emission maximum is also pH dependent, with a red shift of 5 and 6 nm observed for 
compounds 4 and 5, respectively, as the pH increases from 2.5 to 12.5 (Figure 19).  In Figures 
20–21, the spectra are plotted as a function of pH.  As the pH decreases, compounds 4 and 5 
become unquenched; additionally, compound 5 shows a disproportionate increase in the intensity 
of a shoulder found around 560 nm that is not found in compound 4.  Although the origin of this 
shoulder remains yet undetermined, it can be speculated that it may be due to protonation of the 
second nitrogen. These experiments were repeated by other group members using similar 
techniques but the results were inconclusive. 
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Figure 18 Intensity dependence on pH 
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Figure 19 Emission maximum dependence on pH 
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Figure 20 Fluorescence spectra of 4 as a function of pH 
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Figure 21 Fluorescence spectra of 5 as a function of pH 
3.3.3.5 pH dependence of UV Absorption 
Unable to determine the protonation states of DCF-2MPP from the inconclusive 
fluorescence emission results, we decided to attempt a pH titration while simultaneously 
acquiring absorbance and fluorescence spectra.  The resulting absorbance data are shown in 
Figure 22.  Due to the difference in sensitivity between fluorescence and UV-visible 
spectrometers, samples appropriate for absorbance were too concentrated for the more sensitive 
fluorometer, preventing the acquisition of both spectra on the same samples.  Since no clear 
inflection points were present in the absorbance pH titration curve (not shown), the titration was 
not repeated using fluorescence, and the experiment as a whole was abandoned. 
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Figure 22 UV-visible absorbance of DCF-2MPP as a function of pH (data series is pH) 
3.3.4 3D Structure and Conformational Analysis 
Although we were satisfied by the correlation between the HOMO level of the quencher 
and the fluorescent intensity illustrated by the quantum yield values, upon closer inspection the 
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distance between the quenchers and the fluorophore appeared to be too great for efficient PET 
quenching. As shown in Figure 23 (left), we originally anticipated that compound 4 was in an 
open conformation where the piperazine rings were in chair conformations with the DCF-
methylene unit in the equatorial position.  
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Figure 23 Dynamics of compound 4 
 
To determine how such seemingly distant aniline nitrogen atoms are able to participate in 
PET quenching, we investigated the conformation of compounds 4 and DCF-2MPP using two 
dimensional NMR.78 In Figure 24, the results of 500 MHz COSY, NOESY and ROESY 
experiments on compound 4 in DMSO-d6 are shown.79 It was immediately apparent from 
through-space enhancement between the phenyl ring of the quencher moiety and the benzoic 
acid of the fluorophore that the molecule assumed a closed conformation. This observation 
means that either the piperazine rings assume a boat conformation (not shown) or the DCF-
methylene groups occupy axial instead of equatorial positions.  In either case, the aniline 
nitrogen atoms would be proximal to the xanthene ring of the fluorophore, explaining why the 
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phenylpiperazine moieties are able to effectively quench the fluorescence through space by the 
PET mechanism.  Figure 24A shows a 3D representation of the anchor-like conformation 
suggested by the NOESY and ROESY data (for clarity, only one of the phenylpiperazine 
moieties is shown).  Key NOE enhancements are shown in Figure 24B followed by a full list of 
assigned enhancements in Figure 24C.  The strongest evidence for this anchor-shaped 
conformation is the enhancement of protons 6 and 4 of the xanthene and benzoic acid moieties, 
respectively, by protons 8, 9, and 10 of the phenylpiperazine.  This enhancement was present in 
both NOESY and ROESY spectra.  Although we believe that the phenylpiperazine moieties are 
on alternate sides of the xanthene ring, the symmetry of this molecule prevents their 
differentiation in these experiments.  The proximity of the phenyl ring and the aniline nitrogen of 
the phenylpiperazine to the xanthene ring supports the hypothesis of PET quenching.  When 
NOESY spectra were acquired of methoxyphenyl compound DCF-2MPP, it was also found to 
share this anchor-shaped conformation, consistent with its similarly low quantum yield. One 
explanation for the non-entropically favored conformation observed in these molecules is that the 
π stacking interactions between the xanthene and aniline moieties which participate in PET 
quenching also provide sufficient stabilization80 to sustain this conformation in DMSO.  
Attempts to support this conformation via computational methods81 were inconclusive. 
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Figure 24 2D NMR enhancements of compound 4, see text for details. 
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3.3.5 Correlation of Conformation to Fluorescence 
With a picture of the dynamic nature of these sensors emerging, we wanted to understand 
the effect of conformation of the quencher moieties on the fluorescence.  To demonstrate this, we 
needed a way to reversibly “open” the molecule while causing as little perturbation to it as 
possible.  The solution to this problem came to us from another group that had been studying 
inclusion complexes with various cyclodextrins (CD). We reasoned that α- and β-CD, possessing 
millimolar affinities for benzene and substituted aromatic systems,82,83 would bind to the phenyl 
groups of 4 and the anisole groups of DCF-2MPP. This would force the molecule to assume an 
open conformation, reducing the PET rate as described above and enhancing the fluorescence.  
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Figure 25 Fluorescence induction by cyclodextrin 
 
Titration of α-CD (final concentration 100 mM) into a 5 µM solution of DCF-2MPP 
yielded a modest 1.7 fold increase in fluorescence. However, with titration of β-CD (final 
concentration 5 mM), we witnessed a 4.6-fold increase in fluorescent intensity.84 The resulting 
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intensity (Φ ~ 0.14) is similar to that of mono-substituted compound 10 (Φ = 0.176). This 
correlation, coupled to the steric bulk of β-CD, leads us to speculate that β-CD and DCF-2MPP 
form a 1:1 complex in which one of the two p-methoxyphenyl groups is bound to β-CD (Figure 
25). This interaction and resulting conformational change suggests that the unquenching of DCF-
2MPP occurred because the aniline nitrogens of the complexed MPP moiety are now too distant 
from the xanthene ring for efficient PET quenching. To test this hypothesis, we added 1-(4-
methoxyphenyl)-piperazine (MPP) to the mixture of DCF-2MPP and β-CD as a competitor for β-
CD binding. This resulted in a 38% decrease in fluorescence, further supporting our hypothesis 
(Figure 26).  Titration data was also acquired for compound 10 but was inconclusive.  Due to the 
complicated nature of the cyclodextrin interactions, we were unable to construct titration curves 
sufficient to determine binding data.  A possible explanation for this may be in additional 
interactions between the core DCF and cyclodextrins. Cyclodextrins have been shown to 
decrease the fluorescence of fluorescein and related dyes when complexed,85 a phenomena 
running opposite to and possibly interfering with the fluorescence enhancement shown by DCF-
2MPP. 
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Figure 26 DCF-2MPP cyclodextrin titration 
3.3.6 Effect of Metals on Fluorescence 
Since our RNA chelating moieties are structurally similar to intracellular zinc sensors, we 
tested the fluorescence restoration ability of our compounds with various metals.  Figure 27 
shows the results from compounds 4 and 5.  As a control, each metal was tested with DCF. No 
metals were found to enhance fluorescent intensity, indicating that there will likely not be false 
positives due to inter or intra-cellular metal ions if this molecule were to be used in an 
intracellular environment. 
 46 
010000
20000
30000
40000
50000
60000
70000
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 (A
u)
Sample (1 uM concentration)
1 mM Zn
1mM K
1mM Cd
1mM Na
1mM Cu
1mM Mg
1mM Co
1mM Mn
Background
Buffer
1 uM Zn
1uM K
1uM Cd
1uM Na
1uM Cu
1uM Mg
1uM Co
1uM Mn
1um Fe
Buffer
DCF Compound 4 Compound 5
48
5 
nm
 e
x/
52
5 
nm
 e
m
 
Figure 27 Effect of metal ions on fluorescence 
3.3.7 Implications for RNA Detection: A New Approach for RNA Sensors 
Having established that the fluorescence of our DCF derivatives is modulated by PET 
quenching (specifically by the HOMO level of the quenchers and the overall conformation of the 
molecule), we sought to rationally translate this into the development of RNA sensors.  DCF-
2MPP is presumably in equilibrium between open (fluorescent) and closed (quenched) 
conformers (Figure 23). If a specific RNA can be found with the ability to bind only to the open 
conformer, this interaction will shift the equilibrium toward the fluorescent conformer, resulting 
in fluorescence enhancement that can be used to visualize the bound RNA. In addition to this 
conformational change, RNA is likely to bind to the aniline nitrogen atom of the quencher 
moiety via hydrogen bonding or chelation, something not possible in our cyclodextrin 
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experiments, thereby lowering the HOMO energy level of the quencher and potentially resulting 
in further fluorescence enhancement. The challenge is then to find RNA that only binds to the 
open conformation despite the fact that DCF-2MPP prefers the closed conformation. In other 
words, it is crucial to find RNA that does not bind to DCF-2MPP in such a way as to lock the 
closed conformation (i.e., weakly fluorescent conformer). Since the binding of cyclodextrins to 
the MPP moieties of DCF-2MPP was able to elicit fluorescence enhancement, we reasoned that 
if RNA that binds to the MPP moieties could be isolated, the resulting conformational change 
should also elicit a fluorescence increase (Figure 28). 
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Figure 28 A new approach for RNA sensors 
3.4 SYNTHESIS OF AFFINITY MEDIA FOR IN VITRO SELECTION 
3.4.1 Tentagel Resin-bound DCF derivatives 
Before we conducted the spectroscopic analysis necessary to develop the approach 
described above, we planned to isolate RNA for the PET sensors by synthesizing tentagel resin 
bound analogs of the sensor molecules.  Solid phase synthesis of the derivatives was achieved 
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via amide bond formation of the amine substituted tentagel resin with 
carboxydichlorofluorescein directly (Scheme 3).  The resulting DCF substituted resin, 11, was 
further derivatized via Mannich reaction in the same manner as the solution phase reactions in 
Scheme 2.  Compounds 11, 12, 13, and 14 have been verified by 600MHz magic angle spin 
NMR.  Compound 15 was synthesized to serve as a pre-column in the affinity selection, 
removing RNA molecules that bind strongly to the resin and linker from the selection pool. 
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Scheme 3 Solid phase derivitization via amide bond formation 
3.4.1.1 Fluorescence spectra of derivatized solid phase resin 
With the assistance of Professor Simon Watkins of the Center for Biologic Imaging, 
University of Pittsburgh, fluorescence emission spectra were taken of compounds 12-14.  Our 
literature searches indicate no record of such spectra ever being taken of solid phase resin.  
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Figure 29 shows a scanning laser confocal microscope image of compound 14.  Figure 30 shows 
spectra taken during the validation of this new method.  Of particular interest, is the dramatic red 
shift exhibited by all of the spectra.  We speculate that this is due to perturbations in the 
solvation environment by immobilization on the solid support.  Although interesting, this resin 
was abandoned due to change in approach. 
 
Figure 29 Scanning laser confocal microscope 3D composite image of compound 14 
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Figure 30 Emission spectra of solid phase resins 12-14 
3.4.2 MPP Agarose Resin 
Although we originally intended to use agarose resin for its ability to swell in aqueous 
buffers and its demonstrated success at in vitro selection in the literature,86-89 it is not stable at the 
high temperatures necessary for the Mannich reaction, requiring us to use the more temperature 
stable Tentagel resin.  After the change in approach resulting from the cyclodextrin experiments, 
we needed only to have MPP immobilized on a resin. This allowed us to switch back to the 
original plan to use agarose resin for the affinity media.  MPP agarose resin 16 (Scheme 4) 
would allow us to isolate RNA that binds only to the quencher, increasing the odds of 
discovering an RNA that would enhance the fluorescence of 9 through the mechanism described 
above. 
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Scheme 4 Synthesis of MPP agarose 
3.5 ISOLATION OF APTAMERS FOR MPP 
3.5.1 Initial in vitro Selection  
How does one develop RNA that is able to modulate the fluorescence of a PET sensor? 
Well aware that it would be a daunting task to rationally design small molecules that both 
participate in the PET process and bind to specific RNA, we chose to only rationally design the 
PET sensors and to look into alternative approaches to allow us to rapidly develop ligand-RNA 
binding systems without the need for prior insight into the specific RNA-small molecule 
interactions. Since we wished to develop reporter RNAs with universal applicability and minimal 
interactions with endogenous cellular components (similar to the use of tetracysteine moieties in 
the FlAsH method), we decided to concentrate on the use of artificial RNA sequences. The 
answer came in the combinatorial biology method in vitro selection. 
In vitro RNA selection allows for isolating RNAs that possess a rare activity (RNA 
aptamers) from a large pool of random RNA (typically 1013–1015 molecules).90-92 To isolate 
aptamers that bind to a specific ligand, that ligand is typically immobilized on a solid support to 
be used as an affinity column. The RNA pool is incubated on the column, and the non-binding 
RNA is “purified” away. The binding RNA is then eluted and enzymatically amplified to 
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produce a new RNA pool (Figure 31). The process is repeated for several rounds until the pool is 
dominated by binding RNA. 
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Figure 31 In vitro selection 
 
To isolate aptamers for MPP, we synthesized a random RNA library containing a 70 base 
random region flanked by 20 base constant regions on the 5’ and 3’ ends for enzymatic 
manipulation. The layout of the RNA library is depicted in Figure 32 and was based on a library 
received as a gift from the Szostak lab.  
Constant Region (20 bases)
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3'5'
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Figure 32 Schematic of RNA library used in in vitro selection experiments 
 
The initial aptamers were isolated from a pool of approximately 1013 different RNA 
sequences (as working with 1015 molecule library was deemed too expensive). In order to isolate 
aptamers that only bind to MPP and not the resin itself, it is important to remove the vast 
majority of RNA that only binds to the agarose portion of the affinity column.  This is achieved 
by employing negative selection for the first 6 rounds, where the RNA library was first passed 
over the unsubstituted agarose resin before being incubated with the MPP-agarose resin.  To 
further increase the specificity of the aptamers, after the non-binding RNA was washed from the 
affinity column, the binding RNA was then eluted with elution buffer containing 3 mM MPP, 
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preferentially eluting aptamers with affinity for MPP.  After RT-PCR and in vitro transcription to 
generate a new library, the process was repeated for 8 rounds.  After the selection was complete, 
the aptamers were isolated, amplified by RT-PCR, cloned and sequenced. Of the 24 clones 
sequenced, 18 unique RNA sequences were identified and 3 sequences stood out due to their 
presence as multiple copies (indicating dominance in the final pool).  The best represented was 
Apt07 with 5 copies, then Apt01 with 4 copies and finally Apt21 with 3 copies.  The lowest 
energy secondary structure of these aptamers, as predicted by Mfold,93 is depicted in Figure 33. 
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Figure 33 Secondary structures of aptamers from initial selection 
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Figure 34 Structure of DCF-2MPP 
3.5.1.1 Analysis of Hit Aptamers 
To function as reporter sequences, not only did the aptamers need to bind to MPP, they 
also had to bind to the MPP moieties of DCF-2MPP in such a way to enhance its fluorescence.  
In order to screen these aptamers for their fluorescence enhancement ability, it was necessary to 
produce the aptamer RNA on a large scale.  Initially, we attempted to use the restriction enzyme 
EcoR1 to extract the DNA corresponding to the aptamers from the plasmids we used to prepare 
DNA for sequencing.  The aptamer encoding DNA would then be transcribed in vitro using the 
same methods we had used to prepare the library RNA.  Due to the small size of the aptamer 
(110 bases) compared to the pCR4-TOPO plasmid (4k bp) combined with the low yields from 
the plasmid preparations, simply isolating the aptamer DNA from the plasmids would not 
produce sufficient DNA to produce RNA on the scale we needed, even after PCR.  We 
determined that the best method to obtain reproducibly pure aptamer DNA was to have it 
commercially synthesized and use a high-yield commercial transcription kit such as the Promega 
Ribomax®. 
With sufficient amounts of the three aptamers, we screened them for their ability to 
enhance the fluorescence of 9 and 10 by fluorescence titration. Although our original intention 
was to screen the aptamers on a 96 well plate format in a fluorescence plate reader, the Cary 
Eclipse fluorometer to which we had access lacked sufficient sensitivity and dynamic range to 
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directly compare the quenched and unquenched fluorophores on the same plate.  Knowing that 
the Spex fluorometer we used for the fluorescence characterization experiments had this 
capability, we decided to use this instrument with 1 mm x 10 mm quartz cuvettes for the 
fluorescence enhancement studies.  The fluorescent intensity of the sensor was monitored at 
RNA concentrations up to 100 µM for each aptamer. Although two of the three aptamers did not 
demonstrate significant fluorescence enhancement (one showing only 2-fold enhancement and 
another showing no enhancement), one RNA proved to be different; this aptamer, Apt01 (Figure 
35) was found to enhance the fluorescence of DCF-2MPP by 13-fold at the 100 µM 
concentration in a concentration dependent manner. None of the aptamers exhibited any 
enhancement of compound 10, however. As with the cyclodextrin experiment, the addition of 
MPP was found to antagonize the fluorescence induction effect, suggesting that Apt01 binds to 
the MPP quencher moiety, (Figure 36) presumably eliciting a conformational change and 
lowering the HOMO level of the quencher thereby enhancing fluorescence. The titration curve 
implies that the stoichiometry may be 1:1 (Figure 35, inset). Substituting the random N70 RNA 
library for Apt01 did not result in fluorescence enhancement, thus ruling out the possibility of 
non-specific interactions between RNA and DCF-2MPP. 
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Figure 35 Fluorescence induction of compound DCF-2MPP by aptamers. Inset: Plot of peak intensity 
vs [Apt01 RNA] 
 
It is noteworthy that the fluorescence intensity of the DCF-2MPP - Apt01 complex 
exceeds that of compound 10. If Apt01 only binds to and deactivates one of the two MPP 
quencher moieties of DCF-2MPP, the maximum fluorescence enhancement should be 7-fold 
(quantum yield: 0.025 to 0.176). As we were hoping throughout these studies, it is possible that 
the DCF-2MPP - Apt01 binding induces the conformational change of the second MPP due to 
favorable electrostatic interaction between the positively charged piperazine ring and negatively 
charged RNA. This conformational change should result in an increase in the distance between 
the second MPP moiety and the fluorophore, leading to further fluorescence enhancement. 
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Figure 36 Reversal of fluorescence induction by MPP 
3.5.1.2 Mutation Studies 
Once the original stock of the Apt01 dsDNA used to prepare the RNA used in the above 
experiments was consumed and subsequent batches of preparations of template dsDNA did not 
produce RNA capable of producing the same results, it became apparent that some type of 
mutation had occurred somewhere in the preparation of the Apt01 dsDNA. Attempts to amplify 
remaining dsDNA from the original stock yielded DNA incapable of producing fluorescence 
enhancing RNA. We attempted to determine the sequence by RT-PCR of the Apt01 RNA 
followed by standard sequencing, but the results were inconclusive.  Attempts to determine the 
RNA sequence by cleavage of Apt01 using RNAse were mostly inconclusive except for the 
observation that the sequence of the Apt01 RNA was nearly indistinguishable from the intended 
sequence, meaning that any mutations were small point mutations or short deletions.  In light of 
this result, (and to improve binding) we performed mutation studies based on the initial 
secondary structure of Apt01, as predicted by Mfold (depicted in Figure 37).  We tested four 
mutants containing the various deletions and point mutations shown in Figure 37  
 
 58 
 Figure 37 Mutations of Apt01 
 
The mutant aptamers were prepared and tested using the same experimental conditions as 
the RNA titrations with an RNA concentration of 50 µM.  None of the four mutants showed 
fluorescence enhancement.  One possible explanation for these results is incorrect secondary 
structure.  Although initial Mfold results indicate the secondary structure of Apt01 as shown in 
Figure 37, subsequent predictions show a completely different structure as depicted in Figure 33.  
If the secondary structure that we based the mutations on was not correct, the changes that we 
made to the RNA structure may have not resulted in stable conformations similar enough to the 
Apt01 to perform the conformational change necessary to enhance fluorescence.  Future work 
will have to be done to determine which of the possible secondary structures is correct. 
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3.5.2 First Biased Library 
With the lack of success using mutation studies to construct a tighter binding version of 
Apt01, we needed a less rational approach not requiring detailed knowledge of the structure of 
the DCF-2MPP - Apt01 complex.  One such approach was to reisolate aptamers for MPP using a 
library biased toward the sequence of Apt01.  A biased library is based on a desired sequence but 
partially randomized at each nucleotide position during chemical synthesis.  The use of a biased 
library enables the introduction of a controlled number of random point mutations, permitting the 
screening of many mutations simultaneously.  We designed this first biased library to have an 
82% bias toward the Apt01 sequence, meaning that at each nucleotide position, there would be 
an 82% possibility that that base would be the same as the original sequence (wild type) and a 
6% chance that it would be any of the other three bases.  The actual in vitro selection procedure 
was similar to the initial selection, but with two minor changes.  First, we did not do the negative 
selection, rationalizing that since we were starting with a sequence already “purified” of the resin 
binding RNA that it was not necessary.  Second, we introduced a pre-elution step to increase the 
stringency of the selection.  We hypothesized that if we washed the aptamer-bound column with 
a 3 µM MPP solution to elute the weak binding RNA before washing with the 3 mM MPP 
solution to elute the more strongly binding RNA that we could increase the efficiency and 
stringency of the selection by preferentially eluting more tightly binding aptamers.  As before, 
the selection was run for eight rounds, at which point the sequences of the hit aptamers were 
determined. 
Much to our surprise, after the sequencing of 24 clones, we found little or no homology 
between the sequences.  The addition of 10 more clones did little to improve the situation, 
although we were able to find one group of eight closely related sequences, containing a pair of 
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identical sequences (AptB17, Figure 38) in addition to a group of three identical sequences 
(AptB25, Figure 38) and three more pairs of identical sequences, of which we arbitrarily chose 
one to test further (AptB6, Figure 38). 
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Figure 38 Mfold predicted secondary structures of aptamers from the first biased library selection 
 
The biased library aptamers were then produced on a large scale and tested for their 
ability to enhance the fluorescence of DCF-2MPP as described above.  When considering the 
lack of homology in the sequenced hits, it was little surprise when the three aptamers produced 
inconclusive results, without any of them showing fluorescence enhancement.  Upon closer 
inspection of the secondary structures, it occurred to us that the sequences of AptB17 and Apt21 
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were identical.  Despite the fact that this sequence does not enhance the fluorescence of DCF-
2MPP, it is interesting that it was isolated twice using two independent libraries.  One possible 
explanation is that it binds to MPP in such a way that is incompatible with binding to the entire 
DCF-2MPP molecule or binds in such a way so as to not enhance the fluorescence.  Further 
investigation into this hypothesis is necessary once a reliable method is found to study aptamer-
DCF-2MPP and aptamer-MPP binding without the need to monitor fluorescence enhancement. 
3.5.3 Second Biased Library 
These negative results prompted us to revisit the design of the biased library.  The fact 
that none of the biased library hits showed any homology to each other or, most importantly, the 
Apt01 (wild type) sequence on which the library was based, indicated that the library was not 
biased enough toward the wild type.  Based on literature guidelines,94 in order for a 70 random 
base library to have ~85% of the molecules with 3–8 mutations per molecule, it should have a 
degeneracy of ~7%.  Our first biased library had a degeneracy of 18%, meaning that ~85% of the 
library contained between 8 and 17 mutations per molecule.  Although this level of degeneracy is 
sufficient for mutation of short segments, it is too randomized for a large span of 70 bases.  With 
this new information, we resynthesized the biased library to have 7% degeneracy and repeated 
the selection experiment with the new library. 
The selection was performed in a similar fashion to the initial selection, except that it was 
conducted for 10 rounds with the negative selection not being performed in rounds 3-5.  Of the 
12 unique sequences isolated, three sequences most intrigued us (Figure 39); the first, AptB221 
was well represented in the library (with five copies in our sampling), the second, AptB213 was 
also well represented with four copies and the third, AptB212 was the most similar to the wild 
 62 
type, with 87% homology.95 To test the aptamers for their ability to enhance the fluorescence of 
DCF-2MPP, the aptamers were again produced on a large scale and titrated to a maximum RNA 
concentration of 50 µM while monitoring the fluorescent intensity.96  In a departure from 
previous titration experiments, an initial screening step was performed where each aptamer was 
first tested at 50 µM on the Spex fluorometer (Figure 39) for its ability to enhance fluorescence 
before a full titration was performed.  Titrations of the aptamers that showed fluorescence 
enhancement were performed in a 96 well plate format on a Molecular Devices M2 plate reader.  
AptB212 did not significantly enhance the fluorescence of DCF-2MPP, which is not surprising 
due to its lack of wide representation in the collection of sequences determined. However, the 
more represented AptB213 (Figure 41) and AptB221 (Figure 42) aptamers showed 3.8 and 4.1 
times enhancement, respectively. This enhancement is comparable to the 4.7 times enhancement 
exhibited by Apt01 at 50 µM.   
This experiment demonstrates the power of a biased library to improve hit rates in the 
search for signaling aptamers.  In the initial selection, only one of three well represented 
aptamers was capable of enhancing the fluorescence of DCF-2MPP.  After the biased library 
selection, both of the well represented aptamers were capable of fluorescence enhancement, 
displaying rates comparable to the original aptamer the library was based on. 
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Figure 39 Mfold predicted secondary structures of aptamers from the second biased library selection 
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Figure 40 Preliminary screening of second biased library aptamers.  [RNA] = 50 µM 
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Figure 41 Titration of Aptb213 with 1 µM DCF-2MPP 
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Figure 42 Titration of AptB221 with 1 µM DCF-2MPP 
3.5.4 “Less G” Library 
To investigate the effect of fluorescence quenching by guanosine residues suggested by 
Knemeyer, et al97 and Rupcich, et a,l98 we synthesized a new library biased against guanosine.  
Our thinking was that if we were able to isolate aptamers for MPP that contained fewer 
guanosine residues, their ability to enhance the fluorescence would be greater due to the resulting 
decrease in guanosine quenching.  To achieve this, we biased the library to contain 12% G 
instead of the standard 25%.  This selection was conducted simultaneously with the second 
biased library to save time.  Procedurally, nothing was changed from the initial selection, except 
that the negative selection was delayed to the 6th round of to increase initial hit rates with the 
selection being carried through 10 rounds.  Of the 24 sequenced hits, we found one group of 
seven closely related sequences represented by AptG17, one group of three identical sequences 
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(AptG24) and a few sets of two identical sequences. Interestingly, neither of these aptamers 
shows any bias away from the 25% G composition we would have expected (Figure 43). 
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Figure 43 Mfold predicted secondary structures of “Less G” library aptamers. Nucleotide 
compositions are shown in inset 
 
As with the second biased library, the aptamers were produced on a large scale and 
screened at 50 µM on the Spex fluorometer for the enhancement of 1 µM DCF-2MPP (Figure 
44).  Of the two aptamers tested in this way, AptG24 showed enhancement and was subsequently 
titrated using the plate reader method described above (Figure 44, inset). With this method, 
AptG24 was found to enhance the fluorescence of DCF-2MPP by 4.0 fold. Despite the fact that 
we were unable to isolate an RNA aptamer with a lower percentage of guanosine with this 
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selection, the isolation of AptG24 is good support for the generality of the approach, as we have 
demonstrated that aptamers capable of fluorescence enhancement can be isolated from each of 
two completely independent libraries. It is intriguing that AptG24 has 86% homology to Apt01, 
despite the fact that the two libraries were unrelated in sequence.  
It is worthwhile to note that all of the aptamers studied here proved to be quite stable, 
allowing us to recycle and re-purify the RNA many times with no degradation visible by 
polyacrylamide gel electrophoresis. 
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Figure 44 Fluorescence enhancement of “less G” library aptamers. Inset is titration of AptG24 with 1 
µM DCF-2MPP 
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3.6 STUDY OF RNA-SMALL MOLECULE INTERACTIONS 
3.6.1 Electrophoretic Mobility Shift Asays 
After the inability of the first biased library to produce aptamers that would enhance the 
fluorescence of DCF-2MPP, we realized that it would be useful to have an alternate method to 
evaluate the binding between the RNA aptamers and various small molecules (namely MPP and 
DCF-2MPP).  Through personal communication with Dr. Adam Roth of Yale University, we 
decided that by adapting electrophoretic mobility shift assays99,100 (EMSA) commonly used to 
study protein interactions, we should be able to observe RNA-small molecule interactions.  The 
theory behind mobility shift assays is simple: since non-denaturing electrophoresis separates 
species based on their size/diameter as well as their charge, a DNA-protein (or in our case RNA-
small molecule) complex will have substantially different mobility that that of the DNA (or 
RNA) alone.  Provided the complex is stable over the time course of the separation, it is possible 
to evaluate the binding of a pair of species by comparing the bands of the RNA and RNA-small 
molecule complex.  In such a case, KD = [Ligand] x R (R= Ratio of the unbound RNA to bound 
complex).  Therefore, when the bands corresponding to the free RNA and RNA-small molecule 
complex are of equal intensity, the KD is equal to the ligand concentration (small molecule in our 
case).  A typical EMSA gel is depicted in Figure 45.  In this figure, the RNA is denoted by the 
black band and the RNA-small molecule complex is denoted by the blue band.  As the complex 
travels slower than the free RNA, it can be separated and the two bands can be visualized by 
using radioactively labeled RNA or an RNA-specific dye such as Sybr Green II (Molecular 
Probes. Eugene, OR). 
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Figure 45 EMSA assay 
 
DNA-protein interactions have the advantage that they are easy to study using EMSA due 
to the large difference in mobility from the free DNA to the complex.  This comes from the 
significant size and charge change upon binding and stable interactions in the low ionic strength 
buffer used in EMSA.  One of the challenges in studying RNA-small molecule interactions using 
such techniques is that, unlike RNA-protein interactions, there is not a significant difference in 
size when adding a small molecule to an RNA.  Therefore, the majority of the separation will be 
based on the charge difference between the free RNA and the complex with the small molecule 
(typically positively charged).  We felt that through careful optimization of the gel composition 
we would be able to perform such a separation. 
Initially, we used standard 10% acrylamide gels with tris-borate EDTA (TBE) buffer to 
test the ability of the biased library aptamers to bind to MPP.  To accomplish this, we incubated 
aptamer RNA from the first biased library (25 nM) with varying concentrations of MPP and 
loaded the mixtures on the gel. The gel was run and the RNA was detected with Sybr Green II 
dye to compare the bands to see if any shifts occurred (Figure 46).  We did not observe any 
shifts, which is not entirely surprising given that the aptamers from the first biased library 
showed no fluorescence enhancement.  In an attempt to validate this method, we reran the gel 
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using the aptamers from the first selection (two of which having displayed fluorescence 
enhancement).  Again, no shifts were observed (Figure 46). 
 
 
Figure 46 Actual EMSA assay 
 
We then decided to rerun the Apt01 RNA with MPP and also with neomycin, to function 
as a control and verify that RNA can bind to small molecules under these conditions (Figure 47). 
 
Figure 47 EMSA of Apt01 with MPP and neomycin 
 
Much to our delight, we found that Apt01 bound to neomycin at the 100 µM 
concentration.  Why did Apt01 not bind to MPP under these conditions?  We speculated that 
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either the addition of the 5% glycerol necessary to load the solution into the wells or more likely 
the buffer composition preventing binding. The electrophoresis buffer used in these experiments 
was drastically different from the buffer we used for the in vitro selection experiments.  The 
electrophoresis buffer also contained EDTA, which would have chealated the Mg2+ ions 
necessary for RNA to form proper secondary structures.  Subsequent attempts were made with 
various buffers and gel concentrations, but no combination possessed sufficient resolution to 
conclusively replicate the binding observed in solution. 
3.6.2 Capillary Electrophoresis (CE) 
Once we determined that the likely problem plaguing the EMSA experiments was the 
inability to resolve the bound from unbound bands, we envisioned repeating these experiments 
using capillary electrophoresis (CE).  Following the same basic principles as gel electrophoresis, 
CE has the benefit of significantly higher resolution, built-in UV or fluorescence detection, and 
the ability to automate experiments for better reproducibility.   
Initial experiments involved running Apt07 RNA and attempting to determine its affinity 
for MPP (which was previously demonstrated by fluorescence titration).  This was soon deemed 
not possible due to the high ionic strength of the buffer causing Joule heating in the capillary, 
resulting in decreased resolution and broadening of the peak below the detection limit.  Since 
there were no literature guidelines for studying RNA-small molecule interactions with CE, we 
decided to first develop and test a method on a well studied RNA-small molecule system 
(preferably one with low ionic strength binding buffer).   
For such a model system, we turned to the neomycin:Rev-RRE interaction that we had 
used to initiate our project on sensor development. Neomycin has been demonstrated to bind to 
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the 67 base REV response element of HIV-1 virus with 82 nM affinity in vitro70 in a relatively 
low ionic strength buffer (10 mM Tris, pH 7.6, 10 mM MgCl2, 50 mM NH4Cl).  In addition, we 
hypothesized that the +6 charge of neomycin at pH 7.6 would produce a noticeable change in the 
mobility of the RNA upon binding.  Once the conditions were optimized, we were able to detect 
the free RNA, but the RNA:neomycin complex could not be observed. Neomycin could be 
associating with the coating on the capillary wall, thus preventing it from forming a complex 
with the RNA.  Another possible explanation is that, due to the positive charge on the neomycin 
and the extreme difference in mobility between free neomycin (+ charge) and free RNA (- 
charge), the complex will not migrate to the detector in a reasonable amount of time (greater than 
the 120 minute run time of the experiments), thus preventing its detection. 
After the failures with neomycin, with the help and guidance of the Schneider lab at 
Carnegie Mellon University, we decided to move to another test system that was related to 
another project currently being conducted in the Koide group.  The ferritin iron responsive 
element (f-IRE) has been shown to have 3.9 µM affinity for yohimbine101 (Figure 48). In 
addition to this tested affinity, the f-IRE binding buffer used in the literature experiments has a 
low ionic strength (10 mM HEPES, pH 7.2, 40 mM KCl, 3 mM MgCl2), reducing problems 
caused by Joule heating.  The short length of the f-IRE RNA (50 bases) allows it to be 
commercially synthesized, providing a fast route to very pure RNA. 
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Figure 48 Structures of yohimbine, PDMA and orange G 
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In addition to the change in model system, we also instituted the use of the polymer 
sieving matrix PDMA102 (poly(N-N-dimethylacrylamide)) to provide separation based on size 
(similar in concept to the EMSA assays we had previously performed), hypothesizing that the f-
IRE RNA would assume a different conformation in the presence of yohimbine than it would 
free in solution; permitting its separation.  Figure 49 shows a representative set of 
electropherograms.  The chromophore Orange G was run as a reference standard to calibrate the 
migration times.  To evaluate binding, samples consisting of Orange G, Orange G with f-IRE 
RNA, and Orange G with f-IRE RNA and yohimbine were run in triplicate (only one run from 
each is shown in Figure 49 for clarity).  In Figure 49, although it appears that there is a 
measurable difference in the migration time, this is misleading because the run to run variability 
in the migration time is greater than the difference between the migration time of the f-IRE and 
the f-IRE:yohimbine complex. 
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Figure 49 Representative electropherograms 
 
After considering other methods, we concluded that although it may be possible to 
eventually find conditions to provide sufficient resolution to determine kinetic data, these 
conditions would be specific to each system studied. Since the goal was to develop a general 
method to study RNA-small molecule interactions, this approach was put on hold, to hopefully 
be picked up by another researcher or in collaboration with a research group that specializes in 
capillary electrophoresis. 
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4.0  CONCLUSIONS: A NEW PARADIGM FOR RNA SENSORS 
Through the convergence of organic synthesis and combinatorial biology, we have 
developed a new paradigm for the development of fluorescent chemosensors for RNA (Figure 
50).  By following a rational approach toward sensor design, we have demonstrated that it is 
possible to synthesize new PET sensors merely by combining existing fluorophores with 
quenchers possessing appropriate HOMO energy levels, a process that is amenable to building 
combinatorial chemical libraries of PET sensors. After fluorescent and conformational analysis, 
candidate sensors were chosen and RNA aptamers isolated for the quencher units of the selected 
sensors. Once aptamers are isolated, it is possible to morph the sequence into remotely related 
sequences by further in vitro selection using biased libraries.  
PET Sensor
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+
RNA Aptamer for Q
Organic synthesis
RNA Library
+
RNA selection
against quencher
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Figure 50 The new paradigm that emerged from this study 
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Although we have not presented an example here, the independent nature of the 
fluorophore and quencher make it possible to optimize the sensor system by changing the 
fluorophore to fit the particular experiment. Once a satisfactory RNA-sensor system is found, the 
RNA can then be used as a reporter RNA to study gene expression or used to tag endogenous 
RNAs by forming chimeras with the target RNA. This reporter RNA would function in much the 
same way as the protein reporters, with the insertion of the artificial RNA sequence downstream 
of the regulatory domain (similar in concept to Figure 1A). When the gene is activated, the 
reporter RNA is produced and if the appropriate RNA sensor is present, the RNA will bind to 
and enhance its fluorescence. In addition to having low background (the sensor is only 
fluorescent when bound to RNA), such a system has the advantage of being widely applicable, as 
the same reporter RNA-RNA chemosensor pair can be used to monitor the expression of 
virtually any gene. The use of an artificial RNA sequence also has the advantage of being less 
likely to bind to endogenous proteins. The RNA chemosensor DCF-2MPP, the aptamers found to 
enhance its fluorescence, and most importantly the new paradigm they represent are significant 
milestones toward a small molecule-based RNA expression assay. 
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5.0  EXPERIMENTAL 
General techniques. Acetonitrile was dried over 3Å molecular sieves. Yields refer to 
chromatographically and spectroscopically (1H NMR) homogenous materials, unless otherwise 
stated. All reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25-
mm E. Merck silica gel plates (60F-254) using UV-light (254 and 384 nm), 2.4% 
phosphomolybdic acid/1.4% phosphoric acid/5% sulfuric acid in water, anisaldehyde in ethanol, 
or 0.2% ninhydrin in ethanol and heat as developing agents. TSI silica gel (230-400 mesh) was 
used for flash column chromatography. NMR spectra were recorded on AM300 or AM500 
(Bruker) instruments and calibrated using a solvent peak or tetramethylsilane as an internal 
reference. The following abbreviations are used to indicate the multiplicities: s, singlet; d, 
doublet; t, triplet; q, quartet; m, multiplet; br, broad. High-resolution mass spectra were obtained 
by using EBE geometry.  
 
Compound 1: To neomycin B (1.03g, 1.10 mmol) in 10:2:1 DMSO:H2O:triethylamine 
(26 mL total volume) was added 7 equiv (Boc)2O (1.68 g, 7.70 mmol). The resulting mixture 
was heated to 60 °C for 6 h.  The crude product was extracted twice with 2:1 ethyl acetate:H2O 
and washed over brine.  Silica gel flash chromatography in 4.3% MeOH in CH2Cl2 yielded a pale 
white solid in 53% yield.  Attempts to verify this structure by NMR and FAB-MS were 
inconclusive. 
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 Compound 2: Compound 1 (200 mg, 0.164 mmol) was added to 2,4,6-
triisopropylbenzenesulfonyl chloride (1.13 g, 3.73 mmol) and placed under a nitrogen 
atmosphere.  Pyridine (4 mL) was added and the mixture was stirred at 24 °C for 8 days.  The 
reaction was then extracted with ethyl acetate:H2O and neutralized with HCl (1.7 mL).  The 
product was purified via silica gel flash chromatography in 2-5% MeOH in CH2Cl2.  Although 
attempts to verify the structure of this compound by NMR and FAB-MS were inconclusive, the 
mass was able to be verified via ES+MS, calcd MNa2 2+ , 763.5, found 763.5 
 
Compound 3: Compound 2 (10 mg, 6.75 nmol) was added to aminofluorescein (2.3 mg, 
6.75 nmol) and placed under a nitrogen atmosphere.  To this mixture was added N,N-
dimethylformamide (100 µL) and triethylamine (2.8 µL).  The reaction was stirred for 3 h at rt.  
Although spots presumed to be from product were observed via TLC, (10% MeOH in CH2Cl2) 
the product was unable to be purified by silica gel chromatography.  
 
Compound 4 A solution of N-phenylpiperazine (1.82 g, 11.2 mmol) and 
paraformaldehyde (2.40 g, 79.3 mmol) in MeCN (10 mL) were refluxed for 30 min. 
Subsequently, 2',7'-dichlorofluorescein (1.50 g, 3.74 mmol) in H2O/MeCN (80 mL, 1:1) was 
added to the resulting solution and the mixture was refluxed for 21 h in the dark. The organic 
solvent was then removed from the cooled reaction in vacuo. The resulting solution was 
extracted with CH2Cl2 (2 × 200 mL), dried over Na2SO4 and the solvents were evaporated. Silica 
gel flash chromatography of the residue (2.5→5% MeOH in CH2Cl2) was followed by 
recrystallization in CH2Cl2-hexanes to afford compound 1 as a pink solid (2.37 g, 85%). Rf = 
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0.46 (silica, 5% MeOH in CH2Cl2); IR (KBr pellet): νmax = 3431 (br, O-H), 2925, 2814, 1761 
(C=O), 1628, 1596, 1495, 1463, 1396, 1284, 1208, 1090, 997, 922, 893, 757, 697 cm-1; 1H NMR 
(300 MHz, DMSO-d6, 20 °C): δ = 8.05 (br d, J = 7.2 Hz, 1H), 7.84 (br dd, J = 7.2, 7.2 Hz, 1H), 
7.76 (br dd, J = 7.2, 7.2 Hz, 1H), 7.40 (d, J = 7.2 Hz, 1H), 7.20 (br dd, J = 7.2, 7.2 Hz, 4H), 6.93 
(br d, J = 7.2 Hz, 4H), 6.78 (t, J = 7.2 Hz, 2H), 6.64 (s, 2H), 4.16 (s, 4H), 3.22 (br s, 4H), 3.13 
(m, 4H), 2.89 (br s, 4H), 2.59 (m, 4H); 13C NMR (125 MHz, DMSO-d6, 20 °C): δ = 151.1, 150.6, 
126.5, 124.0, 119.3, 118.8, 115.8, 15.4, 109.1, 21.9, 51, 48.1 (21 expected signals); ES HRMS 
calcd for C43H43N4O4Cl2 (M+H)+: 749.2661; found: 749.2679. 
 
Compound 5 A solution of 1-(2-pyridinyl)piperazine (1.82 g, 11.2 mmol) and 
paraformaldehyde (2.40 g, 79.3 mmol) in MeCN (10 mL) were refluxed for 30 min. 
Subsequently, 2',7'-dichlorofluorescein (1.50 g, 3.74 mmol) in H2O/MeCN (80 mL, 1:1) was 
added to the resulting solution and the mixture was refluxed for 21 h in the dark. The organic 
solvent was then removed from the cooled reaction in vacuo. The resulting solution was 
extracted with CH2Cl2 (2 × 200 mL), dried over Na2SO4 and the solvents were evaporated. Silica 
gel flash chromatography of the residue (2.5→5% MeOH in CH2Cl2) was followed by 
recrystallization in CH2Cl2-hexanes to afford compound 4 in 77% yield as a pink solid. Rf 0.41 
(silica, 5% MeOH in CH2Cl2); IR (KBr pellet): νmax = 3435 (br, O-H), 1764 (C=O), 1594, 1479, 
1437, 1400, 1288, 1212, 1094 cm-1; 1H NMR (300 MHz, CD2Cl2, 20 °C): δ = 8.15 (dd, J = 3.6, 
1.2 Hz, 2H), 8.00 (d, J = 7.4 Hz, 1H), 7.76 (ddd, J = 7.4, 7.4, 1.2 Hz, 1H), 7.68 (ddd, J = 7.4, 7.4, 
1.2 Hz, 1H) 7.49 (ddd, J = 8.5, 6.9, 1.2 Hz, 2H), 7.21 (br d, J = 7.4 Hz, 1H), 6.69–6.62 (m, 6H), 
4.12 (d, J = 14.9 Hz, 2H), 4.06 (d, J = 14.9 Hz, 2H), 3.64 (br s, 8H), 2.81 (br s, 8H); Several 13C 
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NMR experiments resulted in no signals; ES HRMS calcd for C40H37Cl2N6O5 (M+H)+: 
751.2202; found: 751.2233. 
 
Compound 6 A solution of 4-hydroxy-4-phenylpiperazine (132 mg, 0.747 mmol) and 
paraformaldehyde (25 mg, 0.798 mmol) in MeCN (10 mL) were refluxed for 30 min. 
Subsequently, 2',7'-dichlorofluorescein (98.2 mg, 0.25 mmol) in H2O/MeCN (80 mL, 1:1) was 
added to the resulting solution and the mixture was refluxed for 21 h in the dark. The organic 
solvent was then removed from the cooled reaction in vacuo. The resulting solution was 
extracted with CH2Cl2 (2 × 200 mL), dried over Na2SO4 and the solvents were evaporated. Silica 
gel flash chromatography of the residue (2.5→5% MeOH in CH2Cl2) was followed by 
recrystallization in CH2Cl2-hexanes to afford compound 2 in 75% yield as a pink solid. Rf = 0.22 
(silica, 10% MeOH in CH2Cl2); IR (KBr pellet): νmax = 3406 (br, O-H), 1760 (C=O), 1571, 1472, 
1370, 1285 cm-1; 1H NMR (300 MHz, DMSO-d6, 20 °C): δ = 8.03 (d, J = 7.5 Hz, 1H), 7.8–7.7 
(m, 2H), 7.49 (br d, J = 7.5 Hz, 4H), 7.35–7.30 (m, 5H), 7.26 (t, J = 7.5 Hz, 2H), 6.70 (s, 2H), ~ 
3.4 (obscured by the solvent), 2.15 (br m, 8H); Several 13C NMR experiments resulted in no 
signals; ES HRMS calcd for C44H41Cl2N2O7 (M+H)+: 779.2291;  found: 779.2334. 
 
Compound 9 (DCF-2MPP) A solution of 1-(4-methoxyphenyl)piperazine (MPP, 1.984 
g, 7.48 mmol) and paraformaldehyde (0.747 g, 24.9 mmol) in MeCN (10 mL) were refluxed for 
30 min. Subsequently, 2',7'-dichlorofluorescein (1.50 g, 3.74 mmol) in H2O/MeCN (80 mL, 1:1) 
was added to the resulting solution and the mixture was refluxed for 21 h in the dark. The 
organic solvent was then removed from the cooled reaction in vacuo. The resulting solution was 
extracted with CH2Cl2 (2 × 200 mL), dried over Na2SO4 and the solvents were evaporated. Silica 
gel flash chromatography of the residue (2.5→5% MeOH in CH2Cl2) was followed by 
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recrystallization in CH2Cl2-hexanes to afford compound 3 in 75% yield as a pink solid. Rf 0.22 
(silica, 5% MeOH in CH2Cl2); IR (KBr pellet): νmax = 3434 (br, O-H), 1765 (C=O), 1512, 1465, 
1285, 1248 cm-1; 1H NMR (300 MHz, DMSO-d6, 20 °C): δ = 8.07 (d, J = 7.5 Hz, 1H), 7.85 (dd, 
J = 7.5, 7.5 Hz, 1H), 7.77 (dd, J = 7.5, 7.5, 1H), 7.41 (d, J = 7.5 Hz, 1H), 6.99-6.76 (br m, 8H) 
6.66 (br s, 2H), 4.18 (br s, 4H), 3.68 (s, 6H), 3.11 (br s, 8H), 2.94 (br s, 8H); Several 13C NMR 
experiments resulted in no signals; ES HRMS calcd for C44H43Cl2N4O7 (M+H)+: 809.2509; 
found: 809.2515.  
 
Compound 11 To Novasyn(™) TG Amino LL Resin (450.7 mg, 0.29 µmol/mg 
substitution) was added O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium 
hexafluorophosphate (HATU, 299.6 mg, 6 eq), 5,(&6)carboxy-2’,7’-dichlorofluorescein (CDCF, 
98.9 mg, 0.225 mmol, 1.7 eq), n-diisopropylethylamine (DIPEA, 203.2 mg, 12 eq), and 1-
methyl-2-pyrrolidone (NMP, 4.5 mL).  The reaction mixture was rotated in the dark at 25 °C for 
7 h.  The solvents were drained and the resin was incubated with DMF for 30 min followed by 
washing with CH2Cl2 (x5).  The resin was then washed with 0.1% HCl in MeOH to remove 
remaining unbound CDCF, yielding a red resin. FTIR (KBr, cm-1) 3436 (OH), 2922, 2866, 2360, 
2342, 1765, 1655, 1627, 1493, 1452, 1350, 1261, 1104, 952, 846, 761, 700.  See also included 
600 MHz magic spin NMR spectrum  
 
Compound 12 N-Phenyl-piperazine (40.1 mg, 0.294 mmol) and paraformaldehyde (61.8 
mg, 2.06 mmol) were refluxed for 30 min in H2O/CH3CN (0.25 mL, 1:1).  Compound 7 resin 
(33.8 mg, 0.29 µmol/mg substitution) and more H2O/CH3CN (1.25 mL, 1:1) were added and the 
refluxing reaction was placed in a shaker (100 RPM) for 48 h.  The resin was then washed with 
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DMF (x5) and CH2Cl2 (x5). FTIR (KBr, cm-1) 3433 (OH), 2961, 2923, 2839, 2360, 2340, 1733, 
1632, 1452, 1258, 1106. See also included.600 MHz magic spin NMR spectrum 
 
Compound 13 1-(2-Pyridinyl)-piperazine (43.4 mg, 0.266 mmol) and paraformaldehyde 
(55.9 mg, 1.86 mmol) were refluxed for 30 min in H2O/CH3CN (0.25 mL, 1:1).  Compound 7 
resin (30.6 mg, 0.29 µmol/mg substitution) and more H2O/CH3CN (1.25 mL, 1:1) were added 
and the refluxing reaction was placed in a shaker (100 RPM) for 48 h.  The resin was then 
washed with DMF (x5) and CH2Cl2 (x5). FTIR (KBr, cm-1) 3444 (OH), 3016, 2923, 2859, 2360, 
1739, 1649, 1454, 1351, 1252, 1107. See also included 600 MHz magic spin NMR spectrum 
 
Compound 14 1-(4-Methoxyphenyl)-piperazine (461.1 mg, 1.74 mmol), NaHCO3 (292.3 
mg, 0.348 mmol) and paraformaldehyde (365.4 mg, 12.18 mmol) were refluxed for 50 min in 
H2O/CH3CN (0.25 mL, 1:1).  Compound 7 resin (33.8 mg, 0.29 µmol/mg substitution) and more 
H2O/CH3CN (1.25 mL, 1:1) were added and the reaction was allowed to reflux for 24 h.  The 
resin was then washed with DMF (x5) and CH2Cl2 (x5) and dried under high vacuum. FTIR 
(KBr, cm-1) 3443 (OH), 2982, 2362, 1639, 1451, 1351, 1249, 1104, 951, 702. See also included 
600 MHz magic spin NMR spectrum  
 
Compound 15 Novasyn(™) TG Amino LL Resin (300 mg, 0.29 µmol/mg substitution), 
benzoyl chloride (11.48 mg, 4.35 mmol), and pyridine (0.7mL) were combined in CH2Cl2 (3.0 
mL) in a sealed container and put on a rotator for 2 h at 24 °C.  The resin was then washed with 
dimethylformamide (DMF, x5) and CH2Cl2 (x5).  Substitution confirmed by Kaiser Test, product 
was pale yellow beads. 
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MPP Resin: To Aminolink™ (Pierce) agarose resin (1200 µL, 1 equiv) was added 1-(4-
methoxyphenyl)-piperazine (MPP, 47.4 mg, 10 equiv), NaOAc (150 mg, 50 equiv), and 
NaBH3CN (27 mg, 43 equiv) in isopropanol (5.1 mL). The mixture was shaken for 2.5 h at 25 °C 
then 20 more equiv. of NaBH3CN was added and shaken for 23 additional hours at the same 
temperature. The resin was then drained and washed with isopropanol (5 mL), H2O (10 mL), and 
incubated with sat. aq. NaHCO3 (10 mL, 30 min). After washing with H2O (2 x 12 mL), the 
white resin was stored in 3 volumes isopropanol at 4 °C. Complete reaction was verified by 
Schiff’s test for free aldehydes (present in unreacted resin).  
 
General spectroscopic methods. The cyclodextrins (Aldrich) and 1-(4-
methoxyphenyl)piperazine dihydrochloride (Acros Organics) were purchased and used as 
received. Phosphate buffers (JT Baker) were used after passage through a 22 micron filter. 
 
UV-visible spectroscopy. Absorption spectra were acquired on a Cary 50 or a Perkin 
Elmer Lambda 19 UV-Visible spectrometer, under the control of Windows-based PC's running 
the manufacturers' supplied software. 
 
Fluorescence spectroscopy. Fluorescence spectra were acquired in a 1 cm × 1 cm quartz 
cuvette on a Spex Fluorolog fluorometer under the control of a Windows-based PC running 
Datamax 32 software. All spectra were corrected for emission intensity using the manufacturer 
supplied photomultiplier curves. 
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Solvent dependence measurements. UV-Visible spectra were acquired on a PC2000-
UV-VIS spectrometer (Ocean Optics, Inc, Dunedin, FL).  Stock solutions (100x) containing 450 
µM of the fluorophore to be tested were prepared in DMSO.  From these stock solutions, 
samples in 0.1N NaOH, MeOH, pH 7.4 phosphate buffer, MeCN, dichloromethane (CH2Cl2), 
and CHCl3 were made to a final concentration of 4.5 µM. Fluorescence spectroscopic analyses 
were performed on a Spex Fluorolog fluorometer using a slit width of 3 nm and photomultiplier 
voltage of 650 V.  Solutions (100x) containing 450 µM of each compound were prepared in 
DMSO and diluted to a final concentration of 4.5 µM with the appropriate solvent. Corrected 
emission spectra were taken at 490 nm excitation. 
 
Quantum yield measurements. Quantum yields were determined using fluorescein in 
0.1 N NaOH (Φ = 0.95) as a standard. To determine quantum yields relative to fluorescein, stock 
solutions of the fluorophores were prepared in DMSO (1 mM) and diluted in phosphate buffer 
(pH 7.0, JT Baker) to OD490 = 0.09. The samples were excited at 490 nm and the integrated 
emission spectra were compared.  To calculate the quantum yield, the corrected emission spectra 
were compared to fluorescein as a quantum yield standard of 0.95 in 0.1 N NaOH.59  The 
following equation was used to relate the integrated peak area of fluorescein to each of the 
unknown compounds. 
∫
∫×Φ=Φ
dards
sample
dardssample emission
emission
tan
tan
 
Fluorescence pH titrations. Phosphate buffers were prepared by adjusting the pH of 4, 7 
or 10 with appropriate amounts of HCl or NaOH until 21 different solutions ranging from pH 
2.51 to pH 12.49 were prepared.  Aliquots of compound 4 or 5 from DMSO stock solutions were 
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taken and combined with each respective buffer to reach a final fluorophore concentration of 4.5 
µM. Corrected emission spectra were acquired from 490 to 660 nm using 490 nm excitation. 
 
UV-Vis pH titration. Solutions of DCF-2MPP (4.5 µM) in quartz cuvettes were 
prepared from the DMSOP stock solution and titrated with HCl or NaOH from pH 0.12 to pH 
11.56. Absorption spectra from 400-600 nm were acquired at each data point using a Perkin 
Elmer Lambda 19. Spectra were corrected for volume changes during titration 
 
Cyclodextrin titration. Solutions of DCF-2MPP (5 μM) in pH 7.4 phosphate buffer (JT 
Baker) were prepared containing 0–100 mM α-cyclodextrin (by serial dilution of a 100 mM 
solution of α-cyclodextrin and DCF-2MPP) or β-cyclodextrin from 0–5.0 mM (from a 10 mM β-
cyclodextrin stock solution in H2O). To test the effect of a competitive inhibitor, MPP (3.75 
mmol for a final concentration of 2.5 mM) was added to a 5.0 mM β-cyclodextrin solution 
containing DCF-2MPP. Samples were excited at 485 nm and integrated emission spectra were 
compared using Origin Pro software. 
 
Effect of metal ions. Stock solutions (10 mM in pH7 phosphate buffer) of ZnCl2, FeCl3, 
CdCl2, MnCl2, CoCl2, MgCl2, CuSO4, NaCl were prepared and filtered through a 22 micron 
filter.  Wells of a 96 well plate were loaded with 1 mM of each metal ion solution and DCF, 
compound 4 or 5 (to a final concentration of 1.0 µM). as well as pH 7.0 phosphate buffer as a 
control.  A second replicate of each well was prepared with a 1 µM concentration of each 
respective metal ion.  Emission spectra were acquired from 490 to 600 nm with excitation at 
485nm using a Cary Eclipse Fluorometer equipped with the plate reader attachment.  The spectra 
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were processed using Datamax software and the intensities at the peak emission intensity were 
compared. 
 
Microscopy and Solid Phase Spectra Acquisition. Confocal images and fluorescence 
spectra were collected on a Zeiss 510 Meta Confocal Laser Scanning Microscope at 10 nm bin 
size using a 488 nm argon ion laser light source and the integrated software.  The beads were 
mounted on glass coverslips and imaged at 20X using confocal imaging ensuring an appropriate 
optical section through the beads. 
 
RNA preparation. DNA templates for the N70 library, biased libraries and 
oligonucleotides used for primer extension and RT-PCR were prepared by automated DNA 
synthesis (Keck Biotechnology Resource Laboratory, Yale University). The random region of 
the N70 library was synthesized with equimolar concentrations of each base in a 0.2 µmol 
synthesis. The partially randomized portions of the biased library were prepared by varying the 
molar proportions of each base during synthesis. Oligonucleotides 40 bases or longer were 
purified by denaturing (8 M urea) PAGE before use. The N70 pool DNA template (1 nmol) was 
made double-stranded by extension in the presence of 5’ PR-N70 primer (5' 
ATGAATACGACTCACTATAGGAGACAGGACTTCG 3’), introducing the promoter for T7 RNA 
polymerase. DNA extension reactions were carried out using Superscript II Reverse 
Transcriptase Polymerase (RT, Gibco BRL) according to manufacturer’s instructions. 
The double-stranded product was then ethanol precipitated, resuspended in TE buffer and 
transcribed in vitro. Typical transcription reactions (100 µL total volume) included 1 µM 
template DNA, 40 mM TRIS (pH 7.8), 2.5 mM spermidine, 0.01% triton X, 2.5 mM each 
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nucleotide triphosphate (ATP, GTP, CTP, UTP), 10 µL T7 polymerase, 10 mM DTT, and 25 
mM MgSO4. Each reaction was incubated at 37 °C for 2.5 h. The RNA was then purified via 
denaturing PAGE, recovered by elution of excised bands in crush-soak buffer (200 mM NaCl, 10 
mM Tris-HCl pH 7.5, 1 mM EDTA pH 8.0), and ethanol-precipitated.  
 
Preparation of Affinity Media. The MPP Resin or Aminolink™ (Pierce) agarose resin 
(120 µL of suspension) was drained of solvent and washed with selection buffer (8 × 100 µL, 
300 mM NaCl, 20 mM Tris-Cl pH 7.4, 5 mM MgCl2)  
 
In vitro RNA Selection. In typical selection experiments, pool RNA (approximately 1013 
molecules, ~900 pmoles) was denatured (100 µL, 300 mM NaCl, 20 mM Tris-Cl pH 7.4, 95 °C, 
3 min), allowed to cool to 24 °C, MgCl2 was added (for a final concentration of 5 mM) and the 
final mixture was added to the MPP resin (50 µL) and incubated at 24 °C for 5 min (unless 
preceded by a negative selection step, in which case the mixture was first incubated on a 50 µL 
column of unreacted aminolink resin under identical conditions). The column was then washed 
with selection buffer (8 x 100 µL) and eluted with elution buffer (8 × 100 µL). Biased library 
RNA was subjected to a pre-elution step where the column was washed with elution buffer 
containing 3 µM MPP prior to elution of binding RNA. RNA from the eluted fractions was 
pooled and ethanol-precipitated with 50 pmol 5’PR-N70 primer and glycogen (0.1 µg) to be 
resuspended directly into a 50 µL RT reaction. The resulting cDNA was amplified by PCR (15 
cycles) with primers 5’PR-N70 and 3’PR-N70 (5' TGGCTCAAGTGCACATGTGC 3’) to generate 
the template for transcription of RNA for the next round of selection. Typical PCR reactions 
used the following conditions: 1.5 mM MgCl2, 2.5 µM each primer, 200 µM each dNTP 
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(Roche), 5 units/100 µL reaction Taq polymerase (Promega) with included buffer. PCR was 
conducted on an Eppendorf MasterCycler Gradient thermocycler using the following program:  
2 min initial denaturation (92.0 °C) followed by 15 cycles of 1 min denaturation (92.0 °C), 1 min 
annealing (40.8 °C) and 1 min extension (72.0 °C) 
 
Cloning final round of selection cDNA into pCR®4-TOPO® vector. The cDNA from 
the final round of selection in each selection experiment was then cloned into the pCR®4-TOPO® 
vector (Invitrogen) and used to transform the included chemically competent cells following the 
manufacturer’s supplied protocol. Cultures were grown of 24 colonies (2.5 mL LB-AMP media) 
and the DNA was isolated using an Eppendorf PerfectPrep Plasmid Mini kit according to the 
manufacturer’s supplied protocol. The plasmid DNA was sent directly to the University of 
Pittsburgh Molecular Medicine Institute DNA Sequencing Core Facility to be sequenced.  
 
Large scale RNA synthesis. RNA for titration experiments was prepared as described 
above except for in vitro transcription. The Promega RiboMAX® high yield transcription kit was 
instead used to synthesize RNA. A typical reaction (150 µL total volume) was run with 7.5 µg 
template DNA and was completed according to the manufacturer’s included protocol. The RNA 
was then phenol/chloroform extracted (x3) and ethanol precipitated. 
 
RNA Fluorescence Titrations. RNA aptamers from the selection experiments were 
tested for their ability to enhance the fluorescence of DCF-2MPP by fluorescence titration in 10 
× 1 mm quartz cuvettes on a Spex Fluorolog. Emission spectra for DCF-2MPP were acquired 
from 500 nm to 670 nm using an excitation wavelength of 490 nm. Samples were prepared 
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containing 100 µM RNA and 1 µM DCF-2MPP (from a 1 mM DMSO stock solution) in buffer 
(300 mM NaCl, 20 mM Tris-Cl pH 7.4). The samples were denatured alongside control solutions 
not containing RNA by heating at 95 °C for 3 min and allowing cool to 24 °C. After the addition 
of MgCl2 (for a final concentration of 5 mM) the solutions were allowed to incubate at 24 °C for 
5 min and the fluorescence emission spectra were obtained. Subsequent data points were 
obtained by dilution. Specifically, 50% of the solution was removed and replaced with an equal 
volume of DCF-2MPP (1 µM) in selection buffer (300 mM NaCl, 5 mM MgCl2, 20 mM Tris-Cl 
pH 7.4) effectively halving the RNA concentration (to a minimum of 812 nM) while keeping the 
chromophore and buffer concentrations constant. Emission spectra were obtained at each data 
point and the peak intensities at 525 nm were used to construct the titration plot. It is important 
to note that the control sample not containing RNA falls in line with the nanomolar titration 
points. 
RNA aptamers from the biased library selection were tested using a similar procedure on 
a Molecular Devices SpectraMax M2 Microplate reader. Excitation was at 490 nm and emission 
spectra were acquired from 505 to 600 nm. The experimental procedure was similar to the one 
described above except that the maximum RNA concentration was 50 µM. 
 
MPP Competition Assay. Samples containing Apt01 RNA (10 µM) and DCF-2MPP (1 
µM) in buffer (300 mM NaCl, 20 mM Tris-Cl pH 7.4) were denatured alongside control 
solutions not containing RNA by heating at 95 °C for 3 min and allowing cool to 25 °C. After 
the addition of MgCl2 (for a final concentration of 5 mM) the solutions were allowed to incubate 
at 24 °C for 5 min and fluorescence emission spectra were obtained. To determine the effect of 
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MPP on Apt01 binding, MPP was added (0.1 µL, neat, to a final concentration of 3.2 mM) to 
each sample. 
 
Mobility Shift Assays. Mobility shift assays were performed using polyacrylamide gels 
(5% and 10%) and either standard tris-borate EDTA (TBE) buffer or selection buffer (300 mM 
NaCl, 5 mM MgCl2, 20 mM Tris-Cl pH 7.4) at various dilutions due to the joule heating caused 
by the high ionic strength.  Despite the buffer and gel composition, the experiments were 
conducted similarly.  Namely, samples containing RNA (25 nM), glycerol (5%; to facilitate gel 
loading), and either the target small molecule (10 or 100 µM) or control lacking small molecule 
were prepared.  After denaturation at 95° C for 2 min and subsequent cooling to 24 °C, the 
samples were loaded on the gel and the gel was run at ~100v for ~60 minutes (depending on the 
gel, gels with higher ionic strength required lower voltages, longer runtimes and buffer 
circulation).  The bands were then stained using Sybr Green II (Molecular probes, Eugene OR) 
and imaged using transillumination at 254 nm with a Stratagene Eagle-Eye camera. 
 
Capillary Electrophoresis of Aptamer and RRE RNA: Typical optimized 
experimental conditions for the Biorad Biofocus 3000 Capillary Electrophoresis apparatus using 
a 50 cm long, coated 50 µm diameter capillary (Zero-Flow; MicroSolv Technologies, 
Eatontown, NJ).  Run voltage was -20 kV for up to 120 mins, 5 second x PSI injection, 20 °C 
Capillary temp, UV Detection at 260 nm. Fresh buffer was used for each run and flushed through 
the capillary for 10 min between runs. Aptamer RNA was run with selection buffer (300 mM 
NaCl, 5 mM MgCl2, 20 mM Tris-Cl pH 7.4) and neomycin:RRE RNA assays were run using the 
buffer described in Werstuck, et al.70 (10 mM Tris, pH 7.6, 10 mM MgCl2, 50 mM NH4Cl).  
 91 
RNA samples were prepared with a final concentration of 21 µM and contained a 80 µM 
Neomycin where applicable.  Each sample was denatured at 80 °C for 2 min and allowed to cool 
to 24 °C before injection into the capillary. 
 Capillary Electrophoresis of F-IRE:yohimbine: All f-IRE experiments were conducted 
on a Beckman P/ACE MDQ Capillary Electrophoresis apparatus in the lab of Jim Schneider in 
the Chemical Engineering Department at Carnegie Mellon University.  The instrument was 
equipped with a photodiode array detector and 20 cm Zero-Flow coated capillary. Although the 
electropherograms used for comparison purposes are from a constant wavelength of 254 nm, the 
initial post-run analysis included a scan from 200-400 nm at each time point to monitor potential 
contamination from protein.  Samples of Orange G (used as a reference marker, 1:40 final 
dilution of 0.1% solution), Orange G with f-IRE RNA (60 µM), and Orange G with RNA and 
yohimbine (50 µM) were prepared. Each sample was denatured at 80 °C for 2 min and allowed 
to cool to 24 °C before injection into the capillary.  Each run was conducted in triplicate and the 
results were analyzed using the manufacturer’s supplied software. 
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6.0  INFRARED AND NMR SPECTRA 
 93 
 Figure 51 IR spectrum of compound 4 (KBr pellet) 
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 Figure 52 1H NMR spectrum of compound 4 in DMSO-d6 (300 MHz) 
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 Figure 53 13C NMR spectrum of compound 4 in DMSO-d6 (75 MHz) 
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 Figure 54 2D COSY NMR spectrum of compound 4 in DMSO-d6  (500 MHz) 
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 Figure 55 NOESY NMR spectrum of compound 4 in DMSO-d6 (500 MHz) 
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 Figure 56 ROESY NMR spectrum of compound 4 in DMSO-d6 (500 MHz) 
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 Figure 57 HMQC NMR spectrum of compound 4 in DMSO-d6 (500 MHz) 
 100 
 Figure 58 IR spectrum of compound 5 (KBr pellet) 
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 Figure 59 1H NMR spectrum of compound 5 in DMSO-d6 (300 MHz)
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 Figure 60 IR spectrum of compound 6 (KBr pellet)
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 Figure 61 1H NMR spectrum of compound 6 in DMSO-d6 (300 MHz)
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 Figure 62 IR spectrum of DCF-2MPP (KBr pellet) 
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 Figure 63 1H NMR spectrum of DCF-2MPP in DMSO-d6 (300 MHz)
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Figure 64 2D COSY NMR of DCF-2MPP in DMSO-d6 (500 MHz) 
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 Figure 65 2D NOEOSY NMR of DCF-2MPP in DMSO-d6 (500 MHz) 
 108 
 Figure 66 IR spectrum of compound 11 (KBr pellet)
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 Figure 67 Magic Angle 1H NMR of compound 11 DMSO-d6 (600 MHz)
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 Figure 68 IR spectrum of compound 12 (KBr pellet) 
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 Figure 69 Magic Angle 1H NMR of compound 12 DMSO-d6 (600 MHz)
 112 
 Figure 70 IR spectrum of compound 13 (KBr pellet) 
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 Figure 71 Magic Angle 1H NMR of compound 13 DMSO-d6 (600 MHz) 
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 Figure 72 IR spectrum of compound 14 (KBr pellet) 
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 Figure 73 Magic Angle 1H NMR of compound 14 DMSO-d6 (600 MHz)
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